var title_f12_57_13200="Elbow x-ray lateral anatomy";
var content_f12_57_13200=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F62567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F62567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral radiograph of the adult elbow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 266px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEKAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5lsDmPA65resJlypHQjuetc1YvtYr2Ira01wXHOMEHPvQB2WhyFpV38Mc8HjIzxXf6HKTJH/tEAKVzxXmOlT77kIAdp7npnNd/o0jqUVWYuuCMnAPPagD0CzkLklzyF4A6emPWteFsKpXflkwdg+UE+ua5rSmLFgzEDh8Dsf8Oa6CymIAVcxDoN/PPegDRR87lQsOgKqOVHc/mK6b4fvu1u63MAfIIxn/AGq5RQ3lxj5UJ6nuRkkc10/w+kD69csAoBgyFPJ+9QB6BJJggDGMVWPL49s9Knl5wMEDNQSEBgO54FAFWQgsCQTnOaezncNxBWm7SPu9ehHWggqyKMcDJoAsqpxxnHYVw3xSk8m1sDyHMhKKDjnBFdsrZTIBznOR3rh/iof9H01znmcrknp8h5HvQByLudjZZi2BnGMAd8mmTTCOSQ7l2qMsOmGzjAz/AEpkQUMcAnoMhsbeevvUUkZHzSElACFz/Cc5zntQAs0i+ersANwJzj5lJGCR7e9RPdnbGpbKlsozLwcfSqySr5vyJyRztJeqrkyfOjlRGWAA7Ee1AGgsnGOcBMKMcBuOvtSSXbrCJBuDtjPzYxj+EfjWdHKftBIZcDncQe3PHvUDXg2MUyqDA5XO9uvPocfzoA13mVJ0ij4SNQNn3dhPQ8dc1QuJ/wB8ViK+aQUxtyWbPSmSPmMq6ghOSc/e9s9hVKdjtBnfcFbhPx4//XQA++ldrd5Cys6KyyAdc44H51zdxKTFtB3DKjBHt19cZIrY3lrUNG4O1SoZgQ3B6DHUVhXYBZ0jRTGDtyARuJ9M/U/kKAKVxMJSpKfeGG+bByOv0rOuWLR70xnJyGqWZyWH3sH17kcf0qvO4EcQBO09B/doA5vVzuDbsgEYOD1NcvNEWfg/N1I9K6i8hZ2fC5c/dz3NZ1xaj5Ag+Yd8cZPegDn3LdB/Ko2Riuew68cCtqbTyFJKsDjqOh9/zrOmt3QNwxUcZ7UAU8EZ5x7UgJ9TU/lnbyCW6fjUbRlfUetADQSOlJmlZCO/P0pMHPTmgAJpd7Zzk02lYYxyDxnigBWIIAAPTnJ60Bj2NMooAeWYnOaAzetNooAfvb1o3t7U3IwOOaSgCTzGpDI3bimUUAO3NjGaKbRQA+FtkoNa9i5VssPl7gj1rF6HNaNq/Q5x70AdVp8iNdRcspVgMZz/AJ4r0HSJ1RkGC2QRkjO0e3vXmsDYeN12gYHzd8/SvQdDcEps3DJzuA7e1AHf6C6FFDM6RlQArdTgYxxXRW7LEcOWHIK7ucfh+dctos4aBCQYzswQ3cc9/wAK6KzbMQ29CAu4dsfXt70AaduzvguS8ffeOepHH4AV0nw9fd4iuD8mTbAD256H3rlnl2ycK2zJOfX2/Oum+HI3a/eEEY8jaeM/NnmgD0ZjnBbPWq7jc55w2eKsthcEYH1qnOxDYGe5NAHD/GPxLrnhLwTd6j4d0YajPGjyS3MkiCGzUEDeyFg0hIJwACOOemD29yuyZgvAU8ADtXJfE7S7nXvh34k0rToVuL+6smjhi3hNz5BAyTjP1x0rrrqRXncq25T0I+lAAhBQ8kfyrgvi0SLTS8KGP2ngep2mu7j+7g8iuA+MeTYaaoDZM5OQcDG00AcgCTE3z5x1OMg9+MdajnJO9Q7pkZweagsZFa3LDBTbyVBLE4wB9abhkU+arbySRtYEYx3/AA4oAqneZ3ViyIE6H72evb1qO7JdiXflSwHHI79f0qS4kxPHIdy5H3hyef4T6d6qwtGxHmICe7ZIwc5J/OgBjsfMLLlVLeYTuxjjGM9hVeTzIZnlV2AXJxu3Kxz0Htz1p8zBE2u6LGX4xnj6+tRFHfzN2VZi24jHAz+h46CgB1tJH+7jkDFdmCCcg56n8DSTSsFg53KAF+ZgAOTzVQyFAXLEjAXjAAHvSOI8SllVZCm31AG7+tAEolXy2Y4ZhwH28L6/yrIu1CKVcYJXAYk+vBx+FX2aSIqwb5kHzMPujPWs+Vx5ID42hyMjp/nmgDDcnIGD5h4+TkD3qu4LqyopIHGSeTzVi6HllogDuZiQR39qS2G6Hdg465K8A/1oAzWtw0hGeW6Ajkj2qpJARwRkA/dHatp4ljmbYcggAD09vakubVGVCM7sHBB4B/nQBki1HzhQMH1H9KpSWgcSAHntkZ/Ct5IWWQhmDMeAMnANPFqGUZUqufmHU0AcfcaWJFl3KEKnscflVK404nLDBJ4/z713HkxspXnrwSOaq/ZEwd2MH5SWHv2/SgDz+WBkbY6YxjnPrUciFVAwApOR612d1YKQWwoVWI3Hn3/Gs680pGcblxlQQB/KgDlzGdwAznpzxUdbdxpZVjtyMZ4J6cVRms5I8lx8vTjtQBSoqZIiSRkA4Od3QVGAOetADKKcOAcgHP6UlACUUtJQAtJRRQAtFJRQApq7Zt8oGOlUqmtmIJAoA6W3JKwnIyV5yevNd34fd3WAnLgg4A/hP0rzu1l2hDwQCD0rt/DM2YNxIJB/T1oA9H0kksARKRwCCwx1+ldRBLtZSrLID0xztA/pXH6K5W52kh1U5U4IFdjbCMjy28sqRhiG2574oAuSEZLliWVgFK/dB6njv1rq/hwNuuXqhvljg4weOtcm4jdUYMwOcHHP6dq6v4Yuj6pfYbP7gHntlv8A61AHo5YFVI4PpVG6J83OTmrmcopxjjpVK6wr9ccZ5oAhAJYfN06YJyPp+NPJG4JgA9QMYqB8MxKvgKcHPFJHKN5yefftQBdjJ4H51578aAP7IsGYlQLwRg5/vKa9AjIABP4VwXxv58L20q5Yx3SME29c8f1oA4LTpittG0jYQttGODgdB9KWRinlhUKhs7VbHI9+Kp2Pyh2BG4fd8wdTjgc/WpxI0QRlBZtpBJ9+aAKzeXvHmcYBB2/KeR059qrqu3aAX25xhlwe2Mc89asMzyPGFjywY7sDGc+v8qryljKpOcfLtBOcjp/MGgCrNIzb49jBsBldl4GfX3qvMQTKwQb35G44bv2/HrWhKpdCwLYDYPy53H1+lVbi3LwsrkjcDh+ooAqyBRJnam1kA55GQOlQbkcrjYrMu7B4Bwc4q5d2SrGwifYpQENt4wMc/U+lZdyzd1LhAQDj14H4ZxQBcXBVmGWO7kDjdk9MVlkbXcgLuU/OfU9qvQHkIrZfy1y5bJU9cY/Oq7oxk3bdp+6cjq3Qn6cUAZN0DJJJyDIOQp4xxUWnqx2xMuT/AAoDg1om2Z7glvlOMbm5waesHlzqI2ZsgElxg54PHoKAMsI6XxVwSy5Zs9iPWpiqhkwrCVSArAfjmrc8e1kfbgKuenUenvVmBgrJy24kDcBxj6dqAKK27yPuCfK4yMtgE+uKZFZvlnQH5eoz1/GtMklfUquArHjPX8abKUWVhb75IwQAX46+vvQBRjs3DeWzYJXIPXHt/Oq09piVvLYtgE5A7dctWwkkal2iJQnBOT0Xp19Mmqk86lUwyKACDgd6AMySzEjAsrZYDazD7px1Hb9KpyQP5TMVHOduVz0Fa0kiOqJ0Qnqehwc/hUMwXySoHQ4J7K3/AOqgDm5LXbK2SQu4/Njrx2zVR7QlsNvU7u/OT6Yropo1Y5ZUwQMYHQ1XubdSArx5zggjscUAchJZiRsMBggnke+M1Ul05S7IgIf0z196602icLgl8E5PTj0qGW0HmuwYknnOP89KAOMlsXQFuo+neoHgdOo7ZrsbywSIkxyuyiMElo9uGx8w98HgHvVM2fyZJUnOcY5OPWgDlcY60VuSWDdAF5HcY5qnLYMnVWHB7dDQBn0Yqd7ZlJAyR0HFRFGGcqeKAGmig5HWigAFSQHD1FSgkHI60Abtkx3Lzx34rtPCzfMyMM7sYB4zXA2kx25JIAAyR1rsfDEjfaRg/wAP3u4PagD1TQDuvFckbiMYHRegrrbd1DyyB1V2ODt5yO34/SuK0Z082HdGzqvGW4GSOtdZaiRkzHgHcRuA+7npQBqiJXk3SbUMeONxyST196674Xn/AImN8IyDH5C/w8k7jXIkBwWYYkcgrtGMDuf0rsPhev8Ap2qOCo/dx42jGcknmgD0FThBzx39qpXRMkoVc9OTjtVmP7vXjOT7iql+N44YquRk9wKAKRGSXk4GeBipGbZsyq9CciqTSnLtyVBITHXt2709l2nG478nBoA1YSGQEnFcT8aUz4Pd87BHPE5cHou6u0teU5Of8K5L4wFV8EaidhPyp16ffFAHlmngmLcoEnKqoJ/hxnnNWZbdSn7tCsaEkljksR/k1X0qNVgOCCqHCsDwDjqfUVckcQuGUbgeflIPr/jQBmOkud6lQwO/ywcZ+vrUcb7DsIA2Eqo7nJ45/OrNx5akCTnIHIXIx2HsarzxjLIeGKgK2eM+v19qAIjcIynBXbknuAAKIH3+X5ZjzuyBgcHnjH4c/WpfkYhZUGUONhHUdD+dVvJHntgg7JBkE4xyc49zxQBYlVIoImAAYNngc56nHbn6VWmh8xcEBnwUVlGNx3cgf/X74p87H7N5u4BN27J7YIxgfjzUUkjKy71URgsynJ9sgD1zj8zQBDBbKs6uTH5pYhmPDDr0/EfhTL21YwhlKcqCxA7nk/XvV7eCsbuGEq44ZAcnHGD3AFV33/LISFUtkAdSOASfrzQBnTx+XKASrLnIHXaRwD9etVZXjEu2QlyRwSfvdMZ/HFaUkMe0KEdpggKkdAuOap7N6qqkEgbCSvPTrQBSumKnf9454yeeR/hTRK5iOASxzx29v51p3tsMBuGdU+UBeAMZFZ7wNGhVcE8khehJ9aAGyMJFCuxbnghQO2MCo0Dhcbwq8ZUcEe+e9S3EM0TDy1454yOG5/xFNEMpjXeqMxKhlPXIPr6c0ARkkKpO5goztY9B7+tQyK+AwOzcMcjr7irjqykM+ehI56CqrOdmSvy4GMfeB9T+NAFSSNiSTkqjbSV/XrimOjkADAycsp6EdOferDMQSSu/OGU9/wAPfnpUTOQrGbIBI6cd6AKp8wy7myc4UHijlt7sTwSBjoD6UoLPJtJOOCAByRSyMhLEr8vXGOmfT0oAroN7FiQrZ3DPbPbH4VHIgSQSbwASQoPb3qyEUIp3c45PY5PT8qBHmcAbAC3THvigDPaIjgKoKjYVJJyOmPejyQnAxgHGT0XPXP41fYc7sDA4HH3R/nn8KheEDcuxgc8uP1FAGbLb7lX5VO4EsrDBFVLuEPuEartwPf8AOtebljtGeS2D39qqspIXaq9eUzQBjyWynzMRkMPmAA79s+1VhbJvG7OX/Lr3rZljYnBJB+9x6g561AY8lSAScBgR1z0NAGJcWOF5HTIPHbNFbU8f7yTaMEEA4HGTRQBxtJS0lAFq0fbkevpXU+Hptk0cgDYUbiP0rkIm2sOcV0WkTshUK2dxxgDmgD1nSG3y+ZvY4wcBup4xxXoNqS5QSfMGw4U8Z9M4ry/RG3xxtsU5IbBPTBr0m1cSGKR4gDxkDv7D8KANWEFlVZS2OrFeOBxgV2/wtVPM1VlB3M0Y+vFcNG8hJZSWIGEyPlYZP616B8N4s2l9IrK2+Ucg98UAdeDg4GahuVJbkAMR6Z4pyEEnnPrmmydQeRjnINAGJ55/eKu0heC23H5fhUiAyRA5PXJwemaddW4jli2rhCWOfc0IDkFiQRjCgcEYoA0LfdjnOehJrmvirj/hEL1AwAMPJwT0Ydh0rp7U7Rg8jFc38SwZNAuF2ZUwsGA/T8KAPItKRXgA3BkT5VGexGcY/rWmd6kozKyDhTjAJPTn/PSsrSXKSxFiqlVwPl9sVrAjGGZVCkqGByGOODj86AM+UokhIcxruyIs8k/7XqPTFRSBY0JYBULAEE7s9encc4qW7iDuC5cHAG4qOMdP6VCEVud2MlS5yeGJ6c/nigBjIrFnfKkrtAHt196icBVJKk5O7kcHJ5Bp0qlLmQReW28A4Ix6DANFwxkjwWZvmI+QcrjqPrigCC4+SMj92xywDMTyB/DioXByvzZYHHl45wMHI/zzirbIQFjMu5um1hwTxj8hVVmI+dXDRkcgKSQQ39aAF+dYTscnafMBI3E89QPT2plyrrEEjUkbS4Y/UHp26n86AnIl5jO7gscZJ64pzFyI3aL5GKgnszfeBP0oAqs4XKxpkFcqS20qM4/lSwhJJIshRDtCsVYk56j9RUcnmK7LI2AMLjHHtg1IsR2Ftm9T8quBjHfn0oAjKuU5R/MlUPId/wAvTpj/AAqOKMOUQgbnbG5ueDjuOpz/ADqWWWQuUUoyhfLVgep7fnmnKwVYfLYLI4wuTgbRjBoAqSoDGEVWLKTxjPHc+x4P50kTB7bqQg6KRlsYx+Ip8sjsNoJOCclSSPvfpUGxjAx35cYOMHjngDn60ANde3lgKwwpx19gPxqvcRmJipBGTuLYx8uc4I/KpZztYGJztOQCBuz7/iKGPmB94JPBJ3ceu7P07UAVNuECkjOdy49ajkTA4yME5TIBqcAGXBOAy4x3b/CoyqyFowvBOSx5xQBntAFBVslse+f/AK9L9m2jcd+QTwRxVndlWYgqTyp/u9jTwihMSZxncuT6nrQBRSEh+pLL15yPYHPemyRlpM5Xdxz6VejAe4ZiyqN27cef0psiAg4cbics4X5RnpxQBR2kqRlNhIKjB6g4waRyVbGMYU9sgfnV2WEqCC3PTaAMZ9T/AEqGWMEMGBY9scD6UAU3J2glxnGeuM/lVcFeGZj/AHSzf0rR+zOVyo+7g4xjHbH51C0WzejbWK/KABnjPU0AZ5COrjDFSuSoGc9fXvUZJ3x7vMKj7p2579OatrEnVwVIbHHIxzQ6sAcgFzg7c9vX2oAoSLGWbKurDnG3OR6UVemGMs21efkPr+FFAHl9FFFACjg1t6U43AfwkYIzwKw60tKfEi5wQCCR7UAem+FLj9wcEMqsV2jjA7f416xprvLYIdxYB923GNx7HHYV4v4QuCJZYyemG+bnA6DmvXtIffaL+9CsoX6igDehDnyzvjCknIPJHJ5+leg/DZSujXHl8Dz3IJFecw7XiJUhV78cnBHf0r0P4bMf7FuwXBxKe+e1AHVWz+buIGBTZP8AWLTLE/unO7LA9qWQgSA5z1oAa6+YpV+B/KqyR+WoDnBzgDHap3faB3B705TvGAdoHc0ATWQ3kKvzE8ehPp68Y9hXL+K9T03V9Mvk0rUbG+FpGy3KWlykrRdiGCtlTn1x6Uz4n3VtY/DHxS17JNFFLYvaBoI/MlLzDy0VV75dgMZHHcdR5jp2lXeieJvATa94L0Xwmg8zT2utMkjk+3XckBRLeYoQVDEMckycgDIyTQBmWXyrHKy/vNm5t3IYdf5V0ESsYt0aFlA25LYxjtj8vzrmNNkVGlVzlA7ICT97n07c8V0NmS8BLgAoVYnqWxz2+oH4UAQ3IURO0nEeScZyTgcjFVV2hSVb96HKBgBgg9e/THSrk6G3t5NwG8DcGBByxPI/KoUQgyFXyVOFA5+Yc8+nf8xQBVlAO4dOQyHHTrn9BUbrl45ElGUO5gVJzjvj0yKsEHfIWRxOx2knJUYGDx9OPwpXHO4klwwXnGNuPegCtkeWSEAjAOwKCDz7fUmqsm1BOEwMY+90I7fU5q6AQ6oSCVA2jdg9cZ/CoY1CnZIwOeULDnoDx26+vrQBUyfI3byACMOrEBfUH3qOXGxC5zvUn5jyc9M47YGKsSqQDI67H6bc8Y/vH1PT86bdIUKBmKEAbipHHIyPTHUfl60AU5YhG+R8zqoUANkfU0iu6ylN+1gm0sSeen5fWrNnp+oajNezWdlJIbWBri4kYFYoUQZKl/u7sc7ep5qzp+gavqVvYXNu+mI99EJ7azuLxIbi5Q8KywkchsEjJG4DigDPj3yKUEki/PndwATjvinzrJuYIoWWU/c2ZAAHb8v1qsSssTGJWBKhXV1w2e+VPQg54PI71KzEThgzli3OWK4z/XkUARhdkmc7Wbjng9eufUYzmnTR4GFCkOinDN3I6+ucgdKqXk0cSLGhMexgzAnBHqM9Kak6rEp/1hB2quMDnjOKAGSMucKSCPvHOc44H0qIAMh27QOACemfekkkj3YZsc4cH1xx6AjmlDKFxuw5wAewP9Px9aAItgYPiPCspYDAxmiWHluWORkq3JNPdVjyN6bRgDcSMnvSStFGcK+7YPnKngqBnj86AK+QrAc4JI45J471IzDbnlkC7cdD9aiaRBhQVKg/wjls0+N1JTecqCeQeMY70ALEqkkl2+UjnGB+f6U4j5gy7twJwCMr+H+NNWba+EYkAbyG7+uR6dal3sEAxhSMM4PLY7CgBkvMOD8i7Tndzt+n5GmlssSFz8vBx1GetSYO1VU7mHyKD2z/AFqR1J6IPuc564HU0AZ2wHOQTISGOe+aiaFnDMN6FRlsj7vvV448x8Z59ORkjgD04FNl+WTLgsjDGfp1BoAzU3eYxySxHUnsfekWLKx7WbavyngYHtU+4DcgdTg4FIduzIILdACM9Oh/OgCGSBvMI2LgnIOOnsaKdLtQZaTcM5IA9qKAPIKKKKACr2ng/eBzjgjNUamtmw+M4BoA7jwzMY70AEsXAQnPUV7BoUoFsseBkncueDj614ZpUuwghvmDDnvivYPDcq7FY71VsHrnaaAO5tpFEqbiBuI9x9K7LwhqthpegavqGq3cNnYWpEkt1OcKg6YPqSeABySQBzXEWx+WNiDkE89MH196uXFnNc6TaS2zWAv9N1m01GC2vJhFDeyqHVYPMPCyPuJQkH5l/GgD0vwN4t8OeLrGaTw1qkGoLbuBMqK8TRA/dyrqrbSO+MEj61pTbto3ESPg5xzXmWn3mv3/AMdNFudY0ODRnbRLuB7Vr1Lq6MKurLLMU4WMyMFQZPzK/tXp16w81hs+bPPNAEIfG4MCG569KkUDYCeCvRex96ghBxIDhgeOWIxVhTgqFALeuTigBNY0nTvEOiXema5ax3dhdoEmhYkBgCGyCOQQVBB4wVBB9eWuvBcVjPp9/fa34h16XS4ybJNVuY5I4JMYE+1I1LyDkBn3EZ9cEdoj8fKPxJxT3CSo8cqLyuM59aAPm3WYl0/xA8jM4gu1MoXH3WPLD8wK0rBtqgBcyLlgd33fl4/oa6nxn4FkmuoJ4bmIRRZ2gg5Xnt61gLpN1b74xAl0shx+4kKmNfXB5z+NACIUaBCxUAgkkjcScdf0qsIZUi24XLlSW7twMVckZY4UASQXK70KkEADHcfSqoYsF3QkZG0EOcg+/tQAwYAKsSjSMV5P3sc0yJBubEh8skKMMM5PHQ025h33CqFZnJKqo+Y+tS3Om3jRiRIW3HI2ZyTjqcen07UAQXBVYFYN8m0EgkZB79KqtcByGVQ4CgHAyQM9fxwD+FPeIeW3mO7CPGSB09gOxpkgJdyRu+8FK8cZ6N05zigCIsoVlaXOGBAYnnH8OD9DVKedmTChAVBZN+W2ckcY7g85q8sK7gsigyYJYZxj0INRGGNUOVl387icnbwRn3FAGj4Su7yVPE+nw3l09rJ4d1GQWfmsYzJsQBtnTODjJqLxTbXOqeN9On0W1m26lHp0+mmMkjYI4QCGA42FHyf4eSazd7pKPs88qB4fKkeFzGXRh8yHHUHuOnFNivtRtrY2ljqmpW9lKrFre1uHjhfOd3yg9++MA0AL4okjn8Wa5cWkoe2l1G6eLHKsPMb5lYdQTkgj1qnG7PG6Ek7Nq5AyFH/6+PrVbYiNs+UMq4wOQ3A49qtW2SHOWKood1UgD0C/nQBXlhLENIhMTcjjDH605YxGUc5X5cgjk49BV+VUW1hIRyAmBnGT7n8vSqg3A/uwEOwckjB9f1xQBUeNVP71MqBkbRyPc++aYYg4cqSGYck96vMVklAE7IQBkbOPTP161TKnz/mkOSd/Aydo460ARtGPPMmBtX36jApHjRY92wFWPJ/vGpJiqyEeYQq5XJ+XpTYFM+14LeSRRyzqhP0UjpQBAVU5JJO7gHjmpoUikjJjUF84z0zxzV6DRdXvAz2umXJHUkgKGH4njqa1bTwP4juT+8jjgaQbirScgEYPT9RQBzPyCVdoCkL0Jx8v070+XLDAkZfSu1tPhteERNdaisQHURJnjrgfl09624PhlasyC6uLuQYzgsACT1P5UAeWeaPKUNkFV6N0HBwT6etI9wYyWKliSRkjtnt35617bbfD7QooVVLRZlAYbn3FjkjH5VsW3hHR7eZZobOASqPmZkyR2/lQB8+Wsd1dNi3t5nBOSAnUCrdv4U168ZwmmyhCCSXYJkGvoxLC0hJwYYyoG0BR0549qV3t48KQFIOCRz+dAHgll8NNeuJVMslpbqSF5beRjPpW1ZfCS4eMPfai5XjHlRgHP49q9bNxbpIwWJiV4AUDLH60j3iogIjC87SGb730/wAaAPP7L4U6PFHCly91cMpJYu3GPoKK7438uGGETHByCSOe38qKAPz8opaSgApVOGBpKKAN7TpSkmVbkLnI5xx1969U8H3LTR25Dh1KjahOMYPX3ryDT3JRWBIIOw89q9A8HXWIyU+RomBOTn9PSgD2KyfeFV3HXqGzgjOeK3/D9pY6xevo2qWsd5pmoQGO4hkGQ6gZHuCDyGBBBAIOa5LTbozRKC4BHGQvQ46V1PhSUJ4m05WIjlAKHB56GgD0fw54U0HwslwPD+nLatd4aaV5ZJpZNuAg8yRmbAA4XJA7A84vykAjPK4wABjP+FS20nmRqDhiCepomiLlR0x6UAVjgAsAcADtUqNnliSSDxjAp0asAAV3AnoTjFSyuYyBGBkjndQBIBheVxz0PamSEqTwDg8jB/CqcbySs38TYHOePpUyTFRgsTnu3UeuKAHXarNatFIrZPRuuK5K90/7Mw3odqtu3qcEn1/+tXYJhoeQSpOBjqRUFxGrs8boMZ7mgDhtV02K6hYoXEhPySLgMvHQ+o9a4y4hayuikzbWVsD5CV5PH1BxXp17Y+XcbB8y5zvLdF9PrXN+MtFkj0z7VChkMJIY7iMxt1/EHB/OgBfA9nDdwao+xTOrom/HbGSR+PH4VPd2ifaDE2/93zhOq/5z+tM+F8jj7QhI5JUMOjEYH+frWr4gTZqBY7gjpnOcAeufyFAHNzaRb3O4XLlJA2Ipk+/GenPY/jXL6/p1/pU5WWFnhZtwuIl+QEDPXp16j1rtmkKNvEb/ALs7GkI9evTtzVuO8fbLEwDRthWRhhSe/B659aAPJ2XzURSybpDtGM/OOufT8KQHas65KkbsuRkFdp6DoM8jA74r0O80XRb5w8cDW0jEsBBJhcAdh0zVH/hA7XBa11q4XeTiOWIMFP1HHegDhJlTZGEUodvzkEDcTnH0pjYeaPzEYEt0I5x7emNpGa7Sf4fXhiVkvrZ1PXahGe+4kVLa/Dm4TDXV8wV1/wCWcfrz1z3oA89vAokf94PLLEgOPvAjIH1HrUCzrHkbmPIJC9OmMf5716xZ+ANMtmSSZpZjn5954Ax0xW7ZaFploii2tYEwFBOBnj1oA8Yt7W9uoYkt7GaQopAfYcHIGM9sitC08JazdOQtjsymAS+MY65HvXsYSGOAHzI0KcEdv0qOS6twoAJLDkYPX6Ht1NAHmMXw+1Sd83F5FCrcHYpLHj69K1YPhjaIFa4vJt5G0iP5AT6V2kmqRwyIGyOcgt83Xn/61I2pttOwBXPJyOnXmgDGsfAujWQjCadHI4QKpclz7n5uAck1rw6daxKsirHGinG0YUHHf68VXfUDGVUz7lHAJGc81HLeIzhSXkKtjcO3oPpzQBobrZAAArNyQ2CTn8Px/OnxXIjI8sZU/NyQceuSeRmqC3cYZnWBcffDNz1P8u9Rx38hkI8mCP5VL5XcSCTjHp0oA1zcMzny1gwOem4t7+3QUw3WBGgeRzycBQoPsDWc11NKGbcI1cnG1cDA5wAOnXH4Uw5aPcrs7DG1uc88HigDQe9kYy4coFwxIcsR6delNNzLKymRpGJHJJ46elVFwxDBXMaNjGckcdT+dCTFWzCjbA+UBBwwPY+9AF9ncSYJDcAEAckUySRyzqB0O0YOQB9fU9aoP9o80KEZY9wBz6Y5I/SnpbzrHtllLIVBGD0OBQBakkeQEnl8jGAOB61EWK/u2QiRTwVXJPpVeSCJB85UYUoGJySOxp6w/IpOSm7GFHOaAJVndVbdGHkBI5PJ4ootrU/KzbycqML+XP60UAfBlFFFABRRRQBZsnKyEDqRx9a7PwpdhLqMDbvcEHPBzXCoxVgw6g5rptLmEc0ciuMgj7vH50Aey6LeY8sq4CsBkHPzHp1H0rstCvUj1fT5pgixxzD3ySMdfqa8z026IQOcZXPynng4yB9a63T5ldAo/wBZs3RkDBB7Y/rQB9B6OylstwoHGR71oSAhiMD3x1Ncr4H1T+0bBJd4Z0Plyjp8+M/1rq2ZW3YLeYvGD0zQA3aAm5c7scZrPclsMWztBPPvxWi67owgJA6kLVWWMEBSp3Hgk9ue9AFcygBUC7lyM+ucUsLkyqp6Nxk+hpkqouQpGD1IpU2q6swXBbnd2FAFqFG3OWDBegCnOPz+lPmUCMszjOQMt7Dmuf8AE1nr+qy6Xp+gX0umafczSHU7+3kQXUUCodiRBweWc4LjlQAelc/8LdRe51LxRp9p4g1DxHoWnPax2OpXbCVzKysZ4vtCgCYLhTntuA54JAO0aMv0IBHbGeKSKFZIpobhFkgmUK6kZ3DuPal8zL4Cgg5Oc81InGXfhSQFAOefU0Ac/o+iJoEphtGLW24mMnsM8D14p/jHUdK06K0bWNT0+xaXd5f2u8jg8xR94rvYbhkjpnrXRRMpdhIow4ypIx831/rXm3jfwnqOtfEefUNJk8I3MVtpcNgYNYha8e3laR5QDEvCFgVw7c7egPWgCa3ltrwG8spEu7aXlJ4ZVkiPYkMpwcEY4NRebEI5G3YVPmyQGPB56e+OKr+HL1NS0NmGnW2m3Njez6Zc2lsR5MM8Ljf5WFUbCWDAY4yQSepuyZLTZ80qQEb7q4LHBx69aAHQrP8AZvtCw3Dw7RiQWz+Wh7kvjGB35otjgxBdrIU4GMjAz/M5re1MQt4v8iyudUivo5BbW0pA+xxER8QtHnJVgDk464PauVsigijdcE4U7jwenIH0oA3Led4o95fCkKqBVwAM+lTtfSR7mkdiuMD5uev6cVmhygV1lZgBkhuBUkO4MFbLDccAn9fpQBZnu3Zl6kYJyWxx+VVGm8xwpCjjk788elSeY0pA527uo54qFogoKszbxy3lgHdjtQBDJN5a4AyTuPQjGOlV58tksT5m0kgHHvmrskLEOCyqpyQMdBj1qhJCTyXWNx82Cc7h1FADiHZsBCFK53Mevb/GlDyQxhFfAwAM/MSfp2FJDG+1VR1DAKr7PlHX/wCtUy2rMWi2mQ7ed0vIX1XHWgCNSGlVSvmMpOOOc/069qlhK8qF272xtIPA7g/7Walt7J2aMmEEYySOScjgc9+BzV2CylZDL8oKtnIHKnvn3oAylibeUIJUAD1xx69KniiOwdVAOcbs4H5c/wBO1bMWkEN+8aNTwwbk844GP0q7FYwQ4aVwHHIAGD7/AP66AOZli2L5YwD1HUgYOcU6bfJGywqYUY+p/Pj3rpxFbRuyxgEE5JI3Zx0pJ7+C2EMkwjjGciRgAAeenvQBgQadNvKhN0QbadoyCcepIrQisZSihkJUer/0FVrrxbpUO8NqEMakDO6ZRz1zisK78e6Iq7f7Qi3AkNsydp9yKAOn+ybUCq2woMjGSfx+lMkhKc/eYYZTkAHn1rgbv4m6WGXZLJLxk4i64B9az734l2zK0kcdx5YI42A8d+fwoA9FfaWUl1GTkgEdSc496d50fPlsPn4O05IOT2/EV5VP8SMJIYrCXy8k7gwHbgfrVNvHUhjAFrKhGCTHJznrj8aAPWJruFkc5A3nGM8jnHT0orxuXxvcMzOlu8ZwQmZtwweSPzooA+caKKKACiiigArS0+XCDjJU5OfSs2pbZ9kyk9M0AepaFdmSLl/b5jjIrtdKuY9iLI5JAwx7r6D6V5d4evMERkgrj5mPNdlp135coJ3Y4LYHP/16APXvh/qq2txI0BPlSYyCOrYwPw969atL2ORw4LYPTJ6fWvmjQNVaC6WRpGj2YCkfxKD0Ne8+GLe5vNEhvLmUQmQnygFxgcUAdZ5gkVgCOOvrVaYhgjNhXJyOfT1rPi863YbwAucbs5Df/Xq4LhJoMFhvPA4/CgCIk52sByc7scUgYsig9sndxzUzLvYOpJOQSVH61AYCZCrEIwGM+uaAOT+KPh7xB4l0S107w7c6THZtcF9Qg1GSeJbuIKAkW6AbtmdxZeCcLzgEHV8FReI9O0q4sfEcHha2gg2LY2/h9Z0jjHzb9yyDA/hxt9WzW9vVFKqQdpwMcc1DM+1dpXLMeFIzmgBN7FyAAfl5PXH0p6uowo5HoB+tNLiGBWkVQ/HTj/OahtpPtErO+FAyEBOMc0AWbfhlUkcH5upwPXpWJ4j8G2Wtau+ow6nrWhapJEILm50W9FubhFBCrIMMGZQThsbhnrwKwfiv8RB8PPDZmsrZL7WpE8yC1ZGeOCESKjTzbSCqbmCDJG5mAHQ1390xjvHQKCFJ2deBkf1oAw7fw1p+naLbaRpNultZ26MkUeWcgMdxJJPzMTySeT+lc/eWiIGt52Yso2kONzHsOh4HQ13zFSFODlMEEHkE1BqGkx30YEi/vAARIvBHOfxoA5K3v7iSIs4tZL4J5YvxAPPK7du0PjOcZG7GcfnUNtp5XaiptcKqlS2eAPvZ5/KrmqXWmeGowdYnde4aOM4H5dKx4vij4URV+ytM68NlYOH7cdzQBtRWLlY2WIkrkqxBI9iB3qyNOlyAwYjghScfWsGb4paEo/di7dVPLeURlfYdqhT4q6BIxD/bQi/fPl4255oA6N9OYF96gqMg44xUUlokUfLcN8w5HX/OKraZ410bULhUhuoi5J2K4KkD8e/NWpZrS45hw0wI4Ru56/pQBTliPlt8inZkgK3O3H6+vSrMOl6VcCaQ3sDmFfMbNtKFHIAwxwMkkAY6ms+9tc4+zy7huxs3EkY7cdOKGjig0rT7SPYZLom8mUZY9SsKjPoAcjsTmgCVWtDGDF98kkgLySOxJz3zzRDtmnISMdOFbgn2GOcVQV4mYGQ+WCArDP3gB047e9ZmpeLtG0Ivbhme6BIaJBnaMcH6H60AdrDYiNVZ2HXnnPT3pmoatpekxeZeXdvFk70Ej4ye4HrXieteP9X1cmG0ZdPhckgR8vg5GCx4HauTlgMrobg+dIvDNI53MoHQ56D6daAPbdS+Kei23FnI1y8Z4ESHoB3JxnmuS1L4n6zdDNhbQQdCXlG5gPbt6VwTL5e4YZlc42gdPr9OKk8tC5A3BDyCTzx2oA2L7xN4kvGbzdXuk+QMqwkIMg8dBWNc/a5cma7lmz08xyV6deuOuanBZg7TAh+SARhfQcDtTcMoKHBGOABn6Y9KAKptY0Dkqu5s5xzj3/mKfJGERUUMAwwRtJwP8akYKB3DKpDDue/H405GbK7huB5OOD6cUAU3iBVtuAzZ+bPB9hTmYMFY5XnPXofcVM4V4kZFUMozwPQ+nr0qGZm+zYwSFZckryAeo/OgBoRdh3Z3n5uV4x2NMAUBiSXQdfw5pxcCCQEAEAZJbkDtx3qOWVkA8sfOcnaBxjGMY9aAGHaoxtAGckd1Hc0UAkACUtgctkD8RRQB45RRRQAUUUUAFFFFAG7ol4EKgtj14613FpNmP5mDPwzDPDH+leYW0pikz+FdVpl6WgZTnG3GN2KAPSfBcD6v4js7cOGC7ncHofp7V9V2caRaLYoAoeOMKT2r5U+C8ol8VSLgFli++w4T5gM4/H9K+rpm8u0tY1O5FUgH1/8ArdaAKN5ErxMj889M9a5nU4NQ0199ozzQHqq5LKPQDv8AXNdS0uXxuKpkjkVE7K7AAq2eMk8D8KAOZsvEU4kkE7A7mCk9MD6VZHiuEqVOzeVBwcn6/pWrPpNpM4kktlZ/7xXj65pjaNZ+YreRHwd2cdB6e/PNADLTUZLqMOJBsb5+BjAq0lwqDdxsXAJY5JpGgQDKAlh0Ucbfc1C8fmyP5i5XHRfWgCH7W1w3DZZyRj0A9q17Rkh2IASTndnvzz16VnIqpyp2scDIHTFS+eAxkBIK5BIXOee1AHlHxU8E+JL7Q/G13p+qQ6tNrJhkSyGm4uRbxzoY7eNxJhVQfMQEy20k8nI9espbq2s7aDVb1b3UETE9ylqIFlbJ5CAnHGB17Z74FK4DzKGEbx8H5iMDgjBPrU0cCRsCXYtnjJ5P+ck0AaltcRBwQ55UZyOOlBuZVDbclPXuM1URVX51RdvQ8c1YjaIcL0wD6/zoAbPFDPG8UiDYxHBGQR3Brkda+H2h3zMVtFhbcNphynIzjp9a7pFXYRgAN8w46jpTBGFyAy8YoA8Z1T4ZyRZ+y38wh2/KrR7seo4rBuPAWuRSfuRaXO//AFmwlGUehr6BlUFicAjJ4+tUgEOU2ENn72OvSgD5tvvDmuWm559NnBJ+Z1GcY/yKrw3eq6f31C2k2lt6k8c4wePY/lX0nJGrKWJAA5I254+nrVSfToJVbzdpkxgccZzkfXqfzoA8Ms/HOsQTAfaY58Jt3Ou38jxzj2p58fahsZEhtiw4MiAsSO/cZOe9eo3vhHTpZAz28TLyQQgABP8AnrWPc/DzS2YBLcx9CcZHfnH4YNAHl2o+JdS1CGaGSUDeOQgKjb6cCsvavbcGfAJYnPHPH/169Vn+G2meYzCOUSjP/LQqTk5yaqv8NLVcRlpipOMI+Bn8fagDzRWGxeHUjj5gSDz0PtTy7NGhfkEj529Mda9BPw1tiu1JrsHG4MHwCPQ0kfw4h81Nsl0cnLt5mCSPSgDgppFIjTZmVhvxkjgjrREd8JZpYflXeiB+TntXbXXw+R9gt5bkHtl87QCRg/lVQ/Du7kVvKu3RQSNuznPQZPpigDl2Mgjc5xIRxk8dSajRv3TGduq5AB5PNdfF8Nb4xyhL8LJtIChepGcg+3Xmm/8ACttRMZVdQg8wcbdh+X3/AAoA5JLjITABZcY7jrnikeRNpHnbhg7SO4/x9q62X4cX/wC9WXU7YlSMlIzgnpRH8N7sKrC9eTdn7ke3HPJGT6UAcpPNlyuT8vfOB9OOlQSXTqqhnYndkg8AgV3cnw6xIC107Iw/jOMnHtQPh3ZEDzHuCgIUAHOT3xQB539pV0dQAV7BhnJz1pHmBYqxw2ckk4+X6130ngGxVTsjui/TvgYP8sVLF4Gsw+TAHAbDCRuuQMcjv1oA81kkBYAyb8fxEEjGaK9PPg21WRVitomR23Et/CAc80UAfK9FFFABRRRQAUUUUAKOtaWnTkDaTgHj6e9ZtOjcqwwaAPWvg9rkem+N7NZyNlwRCcnoxIwf5/nX2JdvFErpJIsaLuk80kkKigsWI9lBNfnjBeywypPAzCVCGDKcYIwQf0FfevhPWR4o8B6Rq1kN9xLZrKkYcLmUIR5ZY9MuMZ7UAc9B42uJ7bT9Ym8N3Nt4a1C4jhgv2v43mRZiqxSvbhfljZmA4csBzg8A9HK4iZfvhgSOgO4g47dK8j8aeJdM8QnTLvS7vVLfx7ZT2wsvC8peSOO+RxkPA6BOFZ/3+5TjBGCMV6Hq8nl61PGiPInnt5TSOQBzjg9x2z3oA0zcvGzneccZUN0prakY3VmYrGCB82PmBGQevSuevL1oMKT+/dicf3eK5iXWGmlJMxYIQXOzJVgDlT7HAPFAHozaxCPMHmoGjB4BwVHcnPt0/Cp/tUbhiSGdQOVHTgEV5zBqVy0MRjht5YvMwfnOCwA4J685HHtW5Z6jEbciWVnl3gsV4GT0HvQB1ZmRCPOkeNQA31JPSkW5Dgi1UKhZgxftg1l2k9xJE0YY7/m2+ZjHJ6HvmnRTSXXmiTaN43sVBBU5A/xoAnnvpI1RlnDbm7E7WyegzVi3lFw77uy8ncTg4qtblQwcsFKHC4+baPXNTvMyytsjZigXc+eGPf8ASgDSgCKq7icMOlWIjhW8vODzhv51mBsqSYcEHdluSB9Ke5LELgK7g4y3IA9aANMzKQFLEkjIGf0FKsrkKNu0c4BPNZX2ibfgqzRdcgDgU43BDlSr7uxIwMUAaP2glhvPJ6D3qMPDInysfck/571WBfLA+WQDwQaWSQqwSMKQONvfPFAEs3lsU3c8kn5e/v7VEzx7VO8NsB6c8/Wq4LlGkkRRgFUy3PHrUCStjOQytjkDgH0oAvGbZvJH7vpkkc1GZkkRd8qMv3mJI78Yqr5jg/w5HBGM9qY0qAfvguWAAyO+c5oA0VCGRQSh4OCDjHrUQW3l3rhwOHJNUTcKVVY2GSx3Y7gdT+Jpv2xiuQuSwO0M3H40AXXt4BzhQSMcdc9qHtggZiimQ/d69KzjqAG0YZELbOBxk98/lStegrhpCXOBtznAzzzmgDQNrIco0aAdQc8nH/1zS/YZC0avyccYPv8A4VmwanL8rbpEQPgyOAVx04p76jtIXLBjzlfmOO447igC5/Z4bZ5jIN4KsM9T6GmtYx4y4LKcgHoffj0qu+oh5G++Fdh8/UsSD/QD6VL5p3O28LkYB35K+/NAEv2WPa6LGgI6j0696DapsUc7TkZIyfpmoVmmWMBJFPAO09znrmlSeXLcLwMFQ3IoASSGLy0A3Z+U8jkLnoPSmPDlCqoSQTuAOPxFK0iRko+4SdtpOcenv1qu7yOzbsKCq9X5wT0P1oAdJbKQECu7OOQx56Y6/rioZbPcULpz0P8AF9G46Y96mYYk2sGUAEArycjpz+lV5TiMsY/kJHGTgnsaAGGEgqwjiQqCvmbfvZz69iOaKjvJVPCq0gDfL7Y65/KigD4VooooAKKKKACiiigApaSigBysR0619K/speNPMgu/Cd4fngSS7sjn7y/8tE/9mH4180V0Xw+8QSeFfGek6zGSPsswZ8d0I2sPyJoA+5tT1CWIyJJJJuKbYznGQORg9e446VhS3eZonmi2nbxOedwHG4e+a0Y7i18R6eptpoluI+Q+d24dcjHY1m3Nt/Z8+LhXUMvDJ8wwM4BPb6deKAMnWg0qqJIy08jYwcMowM5z6msJY5pV8maN1klJKyOnK8DGB2rV1gvbMZjaibzWDRlQfu46j1OfSsiGS6yLhgvmKuBuznbng45oAty2X+kMEjVMEDIcDnru4H0qzY/LNEDJtIB2tjIBIyF579B+NNiSdBCqFJhvHyyKECgL8wZh7dK07fErGKWWBjtDMRt4IPAA/H9KACKaV4ow4BDsRlmB2r6hgeDz+lasMziHapkEHXao6ZJ5/WqkUSMFi23MKrjK+WACc/kT357VdaFEmUNLdAA7gx+Tj0469R+VAFhQi52rCFwCUL8Ad/ft3qdZAEVmCqHznaeG/CmW8ivM7gKSBsc7R09T6ntVtWxszGeW+XIXtQA/aVHytwpDemacbRZW5AIJwSCCTyDT0H7wFlA7dT19MU4MduZAQQSdueVNAEIh3vlkk29ASccjvUghYoNwDk9yeR0/wpY9wVXfJGc4wTwKkUbdwYjqeO5OaABF2fMqAHoSBRIVLIWQsozkY/Omuu/apyM5bcwAx6fWkDBB03E+negBlx5LAbWKjoDjHB71AYUWQEtlBxhVJ/GpWnAYAMfMBO1SQAfX8qaZcLhd5Y8nHGaAISuwKoyBg5xxkeuahlRnZWIICcYHOfp/9erk0y8R7Ac8qSaYx2L826MbuuRyaAM8xMrOjKWI9ePlPp75pk6SAbvkDgYB+8w9q08fOgBDEKwPzZ+valj6ZBDsBzl8cYoAyIo+FXexDngFfl/3j6UkkJRD8si53AjOVGO9ayooJVVfAGc8kHpxRFEQpXeeDxgAYHXNAGQIhuXIMh4B3E/nj0xipo4ZiFLKA6kN0xmtdU8zld6kDJJbk5A6ev0pQEK4QjLZwxkyOOP8aAMaO38tCo8zaBkoRx2PH4ipYImBWRUdSVOVYjAPr+tae+PbIN24EkDJ6r3/AJmlZ41G4KuOMFhz9aAMsgtEwDtgHrgZ9sfiP1p43nBkGcYDAEE596vRXMSRHaoGOQc+vf8AWq76narHukljUj5CSRwR7f1oAi8hpkYM2GxnbjA6daSW03IsagCQgDGeuOc80Sa1YRxgm5tsFcHMo6cZPX0/lUMvivRIlDTanYR4H3fOUfTqfSgCT7O/mbAGdV+YkdcnoAelOjtZFBwrhlIwSdwznp9Kzbnxz4cgGX1nTx/CGEqn+vFUJviN4XjRg+uWfH8PmUAbrWsx8xiu887m6d+tFcrdfFXwnESW1i2ZN3ADFjjjjpRQB8YUUUUAFFFFABRRRQAUUUUAFFFFAHsXwe+Kv/CPvbaZrmTYopjjuF6ouchW9VB6Ecj6V9E/8J74b1ayV9P1ayJdQX/fqNoBPBHr+VfClFAH3g1xb6jZW/2a4hLREYKFWwCe2DWdcaYr3TzicRylRkIcf0r4ngu7i3/1E80X+45X+VWRrWqKcjUr0Z/6bt/jQB9kG2uxceTBBJKhGC+McYzkZqNNKuUczRl8jG2NSAQBnOfXNfIEXiHWoiDFq1+hHAK3DjH61aTxl4lQrt17UxgYH+kv09OtAH12k09vZ4KESIuCCuSw7jOeoqWG8mZIolIIbLAlskqOvB6etfJcXxE8XR/c1++6YGXzge1Nfx/4okx5mrzuVGFLKpK/TigD64/tcrcEyj5EUfcPTPI3fl+dXUv2DEytGpIPCydB78dea+N5fHPiGV98moyM/wDe4BpreNvELbt2pTHcck8ZJoA+zor+PzEZJkLMflzJ0B6fyqT+0UUSFJYyzttYbwcV8T/8JdrpBB1O4wRt4IHHpUf/AAk2sk/Nqd2e3+sP5e9AH3ANRijjMkkhbI2kZxjn696jGsWyR/vLnYWO4l3B3da+ITrl6+WlvblycAkueamTU5CFJnmIJHBcnPWgD7TbXNOBj3ahECV6tIPy60kmu6XE5V7y3dkyWUOOO+Sc8V8Zw3y4ABbjkncTn2qUX2EbEm8HJyOMnjigD7AufEGjIvmJqFrnIx8wCkHqQajPi/QY2Vf7UtNzLnHmgfnXycNRixHkqHIJIPGc1Yiu4Sqqu0DPGBxQB9Ny/EPw0hIN9FnbjBbO36VnTfFTwtEpHnyt5eFCxxFuepPvmvnuWVFJcgbj0AOcYpVlUqCpxknnpjHqaAPdJfjHoaBiLPUJXPTaqgn071nTfG6yWNPs+i3XzY3BnQYHrXiLnYwYlgR6ADJ9x7VG0hIUR4dgdoBOD0zzQB7Bc/HCfa/2XRlXaQR5k+Mn3wOlZVx8aPEBDeTp9jGpG4EF2/D6V5aZCh+cBewG7k00zBVffjLYGex/HrQB6TP8W/F8z7/Os4gDwUtgcD6E/rWdN8S/GB3FtZMe47cJCijP5cCuJ87cud+FJwSD/KnPcYYqzKCQGOw5BoA6Sbxz4vKqr6/eDC4yjAfh0rLuPFGvzIRJreoEn7wM5wfriseW53DbuBZepx6VE91xkAkkcgcUAaD6pqExVpdSvZdnyYadu/f6VWeZ3YmWaSQjIO6RufpVRJ/kC/dI9fbtTvP3ru6rjvx+AFAD02HG4MYz0G/noaja3UNl1QEYIOc54pPtLSN8xJB4wB0HpSGbqwwuCABigCRbdOSI065PFNZU2k7RyMZx0pnnEgncCOpzSCVdpPTj+E/54oAc8a4G5BgHPb0oqF35znJ5HSigDIooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAClBI6UlFAD1dhnBPNL5jAjnOOmajooAn+0Pj6cjjpSee+4nJHHrUNFAF7+0Jd2ckDHODT/7TlChV4HfPOazqKANBtSlxweffnNM+3yeYXwMt1qlRQBdN+5xkZI9aBeHPTFUqKALj3YOCoKn2qSG55Zw4Rh0rPooAsi4bnJHPWmPMTjHb1qGigCYTELxnNO+0MMdCT1zVeigCwJ8cgnPoKHmB6DjtUFFAFjzgwwevc0ef1Pr1FV6KAJTKecEg0VFRQAlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFLSUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUtACUUppKAFpKKWgBKKU0UAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lateral radiograph shows normal elbow alignment. A line extended along the anterior border of the humerus (8) or through the middle of the shaft of the radius would bisect the capitellum (2). The structures shown include: humerus (1), olecranon (3), coronoid process (4), radial head (5), radial neck (6), radial tuberosity (7), and the olecranon fossa (9), which is not well seen on the lateral view.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yochum, TR, Rowe, LJ. Yochum and Rowe's Essentials of Skeletal Radiology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13200=[""].join("\n");
var outline_f12_57_13200=null;
var title_f12_57_13201="Diabetic retinopathy view PI";
var content_f12_57_13201=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F63624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F63624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    How diabetic retinopathy affects vision",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 188px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diabetic retinopathy can impair vision and cause dark spots in your vision.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: the National Eye Institute. Available at:",
"     <a href=\"file://www.nei.nih.gov/health/examples/\" target=\"_blank\">",
"      file://www.nei.nih.gov/health/examples/",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13201=[""].join("\n");
var outline_f12_57_13201=null;
var title_f12_57_13202="Patient information: Vitamin D for babies and children (The Basics)";
var content_f12_57_13202=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86460\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/6/11361\">",
"         Foods and drinks with vitamin D",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/15/5375\">",
"          Bow-legs in children with rickets",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?7/13/7379\">",
"         Patient information: Health and nutrition for women who breastfeed (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?10/45/10962\">",
"         Patient information: Vitamin D deficiency (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?22/60/23491\">",
"         Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/62/15331\">",
"         Patient information: Vitamin D deficiency (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Vitamin D for babies and children (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H97415168\">",
"      <span class=\"h1\">",
"       Why is vitamin D important for babies and children?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Babies and children need vitamin D to grow normally and develop healthy bones.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415185\">",
"      <span class=\"h1\">",
"       What can happen if babies and children don&rsquo;t get enough vitamin D?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Babies and children who don&rsquo;t get enough vitamin D can get a condition called &ldquo;rickets.&rdquo; Rickets can make bones thin and weak. Some children with rickets have legs that bend to the side, called &ldquo;bow-legs&rdquo; (",
"      <a class=\"graphic graphic_picture graphicRef86459 \" href=\"UTD.htm?5/15/5375\">",
"       picture 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415217\">",
"      <span class=\"h1\">",
"       Is my baby or child at risk of getting too little vitamin D?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. If your baby only gets breast milk, or breast milk and some formula, he or she needs extra vitamin D. Breast milk has most of the nutrients a baby needs, but it does not have enough vitamin D in it.",
"     </p>",
"     <p>",
"      Babies and children can also be at risk if they:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have dark skin",
"       </li>",
"       <li>",
"        Do not drink enough milk or eat other foods with vitamin D in them",
"       </li>",
"       <li>",
"        Take certain medicines",
"       </li>",
"       <li>",
"        Were born premature",
"       </li>",
"       <li>",
"        Have a medical condition that makes it hard to get enough vitamin D, such as cystic fibrosis or celiac disease",
"       </li>",
"       <li>",
"        Spend most of their time inside or live in a place with little sun",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415234\">",
"      <span class=\"h1\">",
"       How can I make sure my baby or child gets enough vitamin D?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Vitamin D supplements are the best way to make sure your baby or child gets enough vitamin D for healthy bones. Supplements are pills, capsules, or liquids that have nutrients in them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415251\">",
"      <span class=\"h1\">",
"       How much vitamin D does my baby or child need?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Experts recommend that all babies and children take 400 to 600 international units of vitamin D a day starting a few days after birth. If your child has a condition that makes it hard to get enough vitamin D, he or she might need to take more.",
"     </p>",
"     <p>",
"      Talk to your child&rsquo;s doctor or nurse about which type of vitamin D to give your baby or child, how much, and when to give the supplements. The right dose will depend on your child&rsquo;s diet, whether he or she has any medical conditions, and other factors.",
"     </p>",
"     <p>",
"      It is important not to give your child too much vitamin D. Giving too much vitamin D can make your child sick.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415268\">",
"      <span class=\"h1\">",
"       Is there a test for vitamin D?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your child&rsquo;s doctor or nurse can do a blood test to check your child&rsquo;s vitamin D levels.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415285\">",
"      <span class=\"h1\">",
"       Can my baby or child get vitamin D from foods and drinks?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Foods and drinks that have a lot of vitamin D include (",
"      <a class=\"graphic graphic_figure graphicRef78586 \" href=\"UTD.htm?11/6/11361\">",
"       figure 1",
"      </a>",
"      ):",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Baby formula, milk, orange juice, or yogurt with vitamin D&nbsp;added",
"       </li>",
"       <li>",
"        Cooked salmon or mackerel",
"       </li>",
"       <li>",
"        Canned tuna fish",
"       </li>",
"       <li>",
"        Cereals with vitamin D&nbsp;added",
"       </li>",
"       <li>",
"        Cod liver oil",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your baby or child can also get vitamin D&nbsp;from the sun. The body uses sunlight that shines on the skin to make vitamin D. Playing outside can help your child exercise and get vitamin D at the same time. But it is important to ask your child&rsquo;s doctor or nurse how much sun is enough. Your child should wear sunscreen at least part of the time to prevent sunburn and other conditions caused by too much sun.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H97415319\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7379?source=see_link\">",
"       Patient information: Health and nutrition for women who breastfeed (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/45/10962?source=see_link\">",
"       Patient information: Vitamin D deficiency (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/62/15331?source=see_link\">",
"       Patient information: Vitamin D deficiency (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?12/57/13202?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86460 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-C008A65255-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13202=[""].join("\n");
var outline_f12_57_13202=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415168\">",
"      Why is vitamin D important for babies and children?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415185\">",
"      What can happen if babies and children don&rsquo;t get enough vitamin D?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415217\">",
"      Is my baby or child at risk of getting too little vitamin D?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415234\">",
"      How can I make sure my baby or child gets enough vitamin D?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415251\">",
"      How much vitamin D does my baby or child need?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415268\">",
"      Is there a test for vitamin D?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415285\">",
"      Can my baby or child get vitamin D from foods and drinks?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97415319\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86460\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/6/11361\">",
"      Foods and drinks with vitamin D",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/15/5375\">",
"       Bow-legs in children with rickets",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7379?source=related_link\">",
"      Patient information: Health and nutrition for women who breastfeed (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/62/15331?source=related_link\">",
"      Patient information: Vitamin D deficiency (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/45/10962?source=related_link\">",
"      Patient information: Vitamin D deficiency (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_57_13203="Chapter 4C: Maintenance of cell volume";
var content_f12_57_13203=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 4C: Maintenance of cell volume",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13203/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/57/13203/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 28, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintenance of protein function within the cells generally requires a relatively constant cell volume, although it is possible that it is the concentration of intracellular proteins rather than volume itself that is being regulated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/1\">",
"     1",
"    </a>",
"    ]. This is an important issue for the cells in the medulla, such as those in the thick ascending limb and inner medullary collecting tubule, since the interstitial milieu in which they reside may undergo wide changes in osmolality as illustrated in the following figure (",
"    <a class=\"graphic graphic_figure graphicRef79201 \" href=\"UTD.htm?24/10/24749\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although the luminal membrane of ascending limb cells is impermeable to water, osmotic equilibration with the interstitium can occur across the basolateral membrane. As a result, the rise in interstitial osmolality induced by ADH will cause water movement out of the tubular cells and cell shrinkage. This effect is transient, however, because the cells are able to adapt by increasing their osmolality, thereby holding water within the cells [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. This protective response is, at least acutely, mediated by ADH. Acting on the basolateral membrane, ADH promotes the entry of interstitial NaCl into the cells, apparently by activating parallel Na+-H+ and Cl--HCO3- exchangers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/3\">",
"     3",
"    </a>",
"    ]. A similar process occurs in the inner medullary collecting tubule, which is exposed to the same changes in interstitial osmolality [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/4\">",
"     4",
"    </a>",
"    ] and which has aquaporin-3 and aquaporin-4 water channels in the basolateral membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another defense mechanism in the response to hypertonicity is the generation or uptake of new organic solutes, which leads to the osmotic movement of water into the cell and the restoration of cell volume. These solutes include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    , inositol,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/49/41747?source=see_link\">",
"     betaine",
"    </a>",
"    , taurine, and glycerophosphocholine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. These solutes, which have been called osmolytes, have the advantage that changes in their concentration within the cells do not appear to interfere with enzyme activity. In comparison, an elevation in the cell Na+ or K+ concentration may preserve cell volume at the expense of normal protein function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which osmolyte net production or uptake is enhanced in the thick ascending limb and inner medullary collecting tubule is becoming better understood [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/11\">",
"     11",
"    </a>",
"    ]. One possible signal is the cellular ionic strength (Na+ + K+ concentration) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/8,12\">",
"     8,12",
"    </a>",
"    ]. With hyperosmolality, for example, the osmotic movement of fluid out of the cells plus the initial Na+ and K+ uptake raises the cellular ionic strength. This appears to activate osmotic response elements on the genes that regulate the activity of aldose reductase and the transporters for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/49/41747?source=see_link\">",
"     betaine",
"    </a>",
"    and inositol [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/11,13\">",
"     11,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The activity of aldose reductase, the enzyme that catalyzes the formation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"      from glucose, is increased [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/11,12,14\">",
"       11,12,14",
"      </a>",
"      ]; this change may be accompanied by reduced activity of sorbitol dehydrogenase, thereby diminishing sorbitol conversion to fructose [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is also enhanced activity of Na+-inositol and Na+-",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/49/41747?source=see_link\">",
"       betaine",
"      </a>",
"      cotransporters, changes that will promote the cellular uptake of these solutes [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/11,15\">",
"       11,15",
"      </a>",
"      ]. This increase in transport appears to occur across the basolateral membrane; this is appropriate since the interstitial fluid (which is in equilibrium with the plasma) is likely to have a higher concentration of inositol and betaine than the lumen (due to proximal reabsorption of most of the filtered osmolytes) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The accumulation of glycerophosphocholine (GPC) appears to result from reduced degradation (a change that is mediated by diminished activity of the enzyme GPC:choline phosphodiesterase) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/17\">",
"       17",
"      </a>",
"      ] as well as increased synthesis (from phosphatidylcholine, the precursor of GPC) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The total osmolyte concentration within the cells is another important determinant of osmolyte accumulation. The administration of an aldose reductase inhibitor, for example, will prevent the generation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    ; however, the net response to hyperosmolality is not impaired since the reduction in sorbitol is balanced by an increase in other osmolytes, particularly enhanced uptake of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/49/41747?source=see_link\">",
"     betaine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If, on the other hand, the interstitial osmolality falls (as with a water load), there will be a tendency for water to move into the cells, leading to cell swelling. In this setting, the cell volume is maintained by reversing the above responses. Aldose reductase activity is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/14\">",
"     14",
"    </a>",
"    ] and the excess intracellular",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    and other osmolytes rapidly leak out of the cell due to the expression of specific carriers or channels in the cell membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/6,16,20\">",
"     6,16,20",
"    </a>",
"    ]. Loss of ions, particularly K+ and Cl-, also occurs through specific channels in the luminal and peritubular membrane, respectively (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"UTD.htm?30/62/31725\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13203/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This text is continued separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9378?source=see_link\">",
"     \"Chapter 4D: Tamm-Horsfall mucoprotein\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/1\">",
"      Parker JC. In defense of cell volume? Am J Physiol 1993; 265:C1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/2\">",
"      Sun AM, Saltzberg SN, Kikeri D, Hebert SC. Mechanisms of cell volume regulation by the mouse medullary thick ascending limb of Henle. Kidney Int 1990; 38:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/3\">",
"      Blumenfeld JD, Grossman EB, Sun AM, Hebert SC. Sodium-coupled ion cotransport and the volume regulatory increase response. Kidney Int 1989; 36:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/4\">",
"      Sun A, Hebert SC. Rapid hypertonic cell volume regulation in the perfused inner medullary collecting duct. Kidney Int 1989; 36:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/5\">",
"      Murillo-Carretero MI, Ilund&aacute;in AA, Echevarria M. Regulation of aquaporin mRNA expression in rat kidney by water intake. J Am Soc Nephrol 1999; 10:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/6\">",
"      Garcia-Perez A, Burg MB. Importance of organic osmolytes for osmoregulation by renal medullary cells. Hypertension 1990; 16:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/7\">",
"      Chamberlin ME, Strange K. Anisosmotic cell volume regulation: a comparative view. Am J Physiol 1989; 257:C159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/8\">",
"      Yancey PH, Burg MB. Distribution of major organic osmolytes in rabbit kidneys in diuresis and antidiuresis. Am J Physiol 1989; 257:F602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/9\">",
"      Yamauchi A, Miyai A, Shimada S, et al. Localization and rapid regulation of Na+/myo-inositol cotransporter in rat kidney. J Clin Invest 1995; 96:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/10\">",
"      Nakanishi T, Uyama O, Sugita M. Osmotically regulated taurine content in rat renal inner medulla. Am J Physiol 1991; 261:F957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/11\">",
"      Burg MB. Molecular basis of osmotic regulation. Am J Physiol 1995; 268:F983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/12\">",
"      Uchida S, Garcia-Perez A, Murphy H, Burg M. Signal for induction of aldose reductase in renal medullary cells by high external NaCl. Am J Physiol 1989; 256:C614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/13\">",
"      Ferraris JD, Williams CK, Jung KY, et al. ORE, a eukaryotic minimal essential osmotic response element. The aldose reductase gene in hyperosmotic stress. J Biol Chem 1996; 271:18318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/14\">",
"      Sands JM, Schrader DC. Coordinated response of renal medullary enzymes regulating net sorbitol production in diuresis and antidiuresis. J Am Soc Nephrol 1990; 1:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/15\">",
"      Moeckel GW, Lai LW, Guder WG, et al. Kinetics and osmoregulation of Na(+)-and Cl(-)-dependent betaine transporter in rat renal medulla. Am J Physiol 1997; 272:F100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/16\">",
"      Yamauchi A, Kwon HM, Uchida S, et al. Myo-inositol and betaine transporters regulated by tonicity are basolateral in MDCK cells. Am J Physiol 1991; 261:F197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/17\">",
"      Zablocki K, Miller SP, Garcia-Perez A, Burg MB. Accumulation of glycerophosphocholine (GPC) by renal cells: osmotic regulation of GPC:choline phosphodiesterase. Proc Natl Acad Sci U S A 1991; 88:7820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/18\">",
"      Kwon ED, Jung KY, Edsall LC, et al. Osmotic regulation of synthesis of glycerophosphocholine from phosphatidylcholine in MDCK cells. Am J Physiol 1995; 268:C402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/19\">",
"      Moriyama T, Garcia-Perez A, Olson AD, Burg MB. Intracellular betaine substitutes for sorbitol in protecting renal medullary cells from hypertonicity. Am J Physiol 1991; 260:F494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13203/abstract/20\">",
"      Siebens AW, Spring KR. A novel sorbitol transport mechanism in cultured renal papillary epithelial cells. Am J Physiol 1989; 257:F937.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7284 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-168C04E0CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13203=[""].join("\n");
var outline_f12_57_13203=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7284\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7284|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/10/24749\" title=\"figure 1\">",
"      Papillary composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/62/31725\" title=\"figure 2\">",
"      Loop of Henle transport",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9378?source=related_link\">",
"      Chapter 4D: Tamm-Horsfall mucoprotein",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_57_13204="UPJ obstruction ultrasound";
var content_f12_57_13204=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound of a unilateral left ureteropelvic junction obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 577px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasonography demonstrates calyceal and renal pelvic dilatition of the left kidney and a normal appearing right kidney.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Laurence S Baskin.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13204=[""].join("\n");
var outline_f12_57_13204=null;
var title_f12_57_13205="Great toe amputation";
var content_f12_57_13205=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F56269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F56269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Great toe amputation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 688px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13205=[""].join("\n");
var outline_f12_57_13205=null;
var title_f12_57_13206="Antihypertensive therapy and progression of chronic kidney disease: Experimental studies";
var content_f12_57_13206=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13206/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13206/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13206/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13206/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13206/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13206/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/57/13206/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive studies in animals and humans have shown that progression of a variety of chronic renal diseases may be largely due to secondary hemodynamic and metabolic factors, rather than the activity of the underlying disorder. Identification of these factors, such as intraglomerular hypertension and glomerular hypertrophy, is important clinically because they can be treated, possibly preventing or minimizing further glomerular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. A review of the mechanisms by which these alterations might occur and how they might induce glomerular injury is available elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26938?source=see_link\">",
"     \"Secondary factors and progression of chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An important component of this approach is antihypertensive therapy, particularly with angiotensin converting enzyme inhibitors. The experimental studies supporting this approach will be reviewed here. The clinical trials and recommendations are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREFERENTIAL EFFECT OF ACE INHIBITORS ON RENAL HEMODYNAMICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;From a therapeutic viewpoint, lowering the systemic blood pressure is beneficial in a variety of experimental renal diseases, at least in part by reducing the intraglomerular pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/1,2,4,5\">",
"     1,2,4,5",
"    </a>",
"    ]. Angiotensin converting enzyme (ACE) inhibitors appear to be particularly effective in this regard; this effect may be related to reversal of the angiotensin II-induced increase in resistance at the efferent or postglomerular arteriole [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Dilatation of the efferent arteriole will facilitate blood movement out of the glomerulus, lowering the intraglomerular pressure independent of any change in systemic blood pressure. A brief review of the actions of angiotensin II on glomerular hemodynamics is available elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=see_link\">",
"     \"Renal effects of ACE inhibitors in hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is presumed that the deleterious effect of angiotensin II represents",
"    <strong>",
"     local generation",
"    </strong>",
"    , since circulating levels are normal or reduced (due to volume expansion) in many patients with chronic renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/6\">",
"     6",
"    </a>",
"    ]. In the remnant kidney model of chronic renal failure, for example, endothelial injury or activation is associated with enhanced expression of angiotensinogen mRNA, which may then lead to increases in angiotensinogen and angiotensin II production [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Angiotensin receptor blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data in animal models concerning the efficacy of angiotensin II receptor antagonists in protecting against progressive renal failure are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/8\">",
"     8",
"    </a>",
"    ]. Some studies have found that angiotensin II receptor antagonists are as effective as ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparison, other experimental studies have shown that angiotensin II receptor antagonists (ARBs) had a lesser antiproteinuric effect than ACE inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/8,14\">",
"     8,14",
"    </a>",
"    ]. This difference appeared to be mediated by kinins, which contribute to efferent arteriolar dilatation and the desirable reduction in intraglomerular pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/8,14\">",
"     8,14",
"    </a>",
"    ]. ACE is also a kininase; thus, kinin levels increase after ACE inhibition, an effect not seen with angiotensin II receptor antagonists.",
"   </p>",
"   <p>",
"    With experimental models, some variability in results may be due to differences in dosing, with most drug dosing being based on the maximal effects observed on blood pressure. In some experimental studies, much higher levels of angiotensin-I receptor are noted in renal parenchyma than in vascular smooth muscle cells [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/15\">",
"     15",
"    </a>",
"    ]. This suggests that higher doses of ARBs may be required to effectively block renal parenchymal receptors than the doses used to lower the blood pressure. These much higher doses may confer effects beyond that obtained with blood pressure lowering, particularly decreased inflammation and superior nephroprotection.",
"   </p>",
"   <p>",
"    This hypothesis was evaluated in the",
"    <span class=\"nowrap\">",
"     5/6",
"    </span>",
"    renal ablation model in which conventional doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    (L50) were compared with 10 fold higher doses of losartan (L500) as well as",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"      hydrochlorothiazide",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"      hydralazine",
"     </a>",
"    </span>",
"    (HH) at doses to obtain similar blood pressure effects as with high dose losartan [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/16\">",
"     16",
"    </a>",
"    ]. Among the effects measured, glomerular pressure and glomerular filtration rate were similar with both L50 and L500, although blood pressure and renal vascular resistance were lower with L500. Although renal injury and albuminuria were partially reduced by L50 at 4 months post-surgery, L500 completely arrested renal inflammation and injury and was associated with regression of albuminuria. This finding suggests that full blockade of angiotensin-I receptor blockers requiring much higher doses of ARBs may be associated with maximum nephroprotection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Other antihypertensive drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other drugs, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"     hydralazine",
"    </a>",
"    , diuretics, and beta blockers, are less likely to reverse intraglomerular hypertension (because they do not produce preferential efferent dilatation) and therefore may be less likely to protect against progressive glomerular injury (",
"    <a class=\"graphic graphic_figure graphicRef53771 \" href=\"UTD.htm?14/48/15117\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/5\">",
"     5",
"    </a>",
"    ]. Hydralazine and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"     nifedipine",
"    </a>",
"    , for example, appear to produce prominent afferent or preglomerular arteriolar dilatation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/5,17,18\">",
"     5,17,18",
"    </a>",
"    ]. Decreased resistance at this site will allow more of the systemic pressure to be transmitted to the glomerulus, possibly producing no change or even an elevation in intraglomerular pressure despite the associated reduction in systemic blood pressure. Increased efferent resistance also may occur, as the drug-induced vasodilatation leads to activation of the renin-angiotensin system. In comparison to nifedipine, the other calcium channel blockers &mdash;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    &mdash; are less potent vasodilators and may primarily decrease the resistance at the efferent arteriole, similar to the ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies using calcium channel blockers in experimental models of renal disease have revealed conflicting results [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/17\">",
"     17",
"    </a>",
"    ]: some have shown increasing proteinuria (consistent with a rise in intraglomerular pressure) and little protection against glomerulosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/18\">",
"     18",
"    </a>",
"    ], while others have shown benefit by mechanisms that may in part be independent of the intraglomerular pressure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26938?source=see_link\">",
"     \"Secondary factors and progression of chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     OTHER ACTIONS OF ACE INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to lowering the intraglomerular pressure, experimental studies suggest that the beneficial effect of ACE inhibitors may also be related to a number of other factors (",
"    <a class=\"graphic graphic_figure graphicRef86383 \" href=\"UTD.htm?11/58/12207\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Angiotensin II is a growth factor; therefore, diminishing its production may minimize glomerular hypertrophy which, by decreasing the capillary radius, can reduce the tension on the glomerular capillary wall [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. This protective effect also may occur in extrarenal vessels, as the degree of vascular hypertrophy in hypertensive animals with renal disease is less following therapy with an ACE inhibitor than with the triad of a thiazide diuretic,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16950?source=see_link\">",
"       reserpine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"       hydralazine",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/10\">",
"       10",
"      </a>",
"      ]. Inhibition of local angiotensin II generation may be responsible for this vasculoprotective effect. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=see_link\">",
"       \"Renin-angiotensin system inhibition in the treatment of hypertension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Angiotensin II, either directly or via increased glomerular pressure, can enhance the release of extracellular matrix and collagen from mesangial and tubular cells, thereby promoting both glomerular and tubulointerstitial fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/7,19-22\">",
"       7,19-22",
"      </a>",
"      ]. This effect is mediated at least in part by enhanced release of transforming growth factor-beta, matrix proteins, platelet-derived growth, and plasminogen activator inhibitor-I [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/7,21,23-26\">",
"       7,21,23-26",
"      </a>",
"      ]. Administration of an ACE inhibitor",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      angiotensin II receptor blocker decreases cytokine release, due most likely to a fall in glomerular pressure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      reversal of the direct action of angiotensin II [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ability of ACE inhibitors",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angiotensin II receptor blockers to block the profibrotic effect of angiotensin II may be particularly due to their effect to decrease transforming growth factor-beta and plasminogen activator inhibitor-I levels (among others),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increase hepatocyte growth factor concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/27\">",
"     27",
"    </a>",
"    ]. Due to these effects, ACE inhibitors and angiotensin II receptor blockers may help reverse renal sclerosis, as observed in multiple animal models of progressive kidney dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/25,26,28\">",
"     25,26,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An ACE inhibitor may directly improve the size selective properties of the glomerulus, thereby preventing the accumulation of macromolecules in the mesangium and a secondary increase in mesangial matrix production [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/29\">",
"       29",
"      </a>",
"      ]. Whether this effect is related to or is independent of the associated reduction in intraglomerular pressure is not clear.",
"     </li>",
"     <li>",
"      Inhibition of angiotensin II production via ACE inhibition also lowers the release of aldosterone. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26938?source=see_link&amp;anchor=H13#H13\">",
"       \"Secondary factors and progression of chronic kidney disease\", section on 'Aldosterone'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Due to decreased degradation, ACE inhibitors increase bradykinin concentrations, which may ameliorate renal tubulointerstitial fibrosis. Support for this was provided by an animal model in which unilateral ureteral obstruction-induced interstitial fibrosis was significantly increased in bradykinin B2 receptor knockout mice [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13206/abstract/30\">",
"       30",
"      </a>",
"      ]. Bradykinin may dampen fibrosis by increasing extracellular matrix degradation via enhanced metalloproteinase-2 and other enzymatic activity. A similar benefit by this mechanism would not be expected with an angiotensin II receptor blocker, which does not increase bradykinin levels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     POSSIBLE ROLE OF ENDOTHELIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelin, a potent peripheral vasoconstrictor, has also been implicated in the progression of renal failure, due in part to its ability to stimulate glomerular hypertrophy and extracellular matrix stimulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35925?source=see_link\">",
"     \"Endothelin and the kidney\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2199613\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progression of a variety of chronic renal diseases may be largely due to secondary hemodynamic and metabolic factors, rather than the activity of the underlying disorder. Antihypertensive therapy, particularly with angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), is one important component of reducing risk of secondary renal injury. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Data in animal models concerning the efficacy of ARBs in slowing chronic kidney disease are conflicting. Some studies have found that ARBs are as effective as ACE inhibitors. In comparison, other experimental studies have shown that ARBs have a lesser antiproteinuric effect than ACE inhibitors. This difference appeared to be mediated by the ACE inhibitor induced increase in kinins, which contribute to efferent arteriolar dilatation and the desirable reduction in intraglomerular pressure. However, some variability in the results comparing ARBs with ACE inhibitors may be due to differences in dosing; higher doses of ARBs may be required to effectively block renal parenchymal receptors than the doses used to lower the blood pressure. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Angiotensin receptor blockers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"       Hydralazine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"       nifedipine",
"      </a>",
"      appear to produce prominent afferent or preglomerular arteriolar dilatation, and result in an elevation in intraglomerular pressure secondary to inhibiting renal autoregulation despite the associated reduction in systemic blood pressure. In comparison to nifedipine, the other calcium channel blockers &mdash;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"       diltiazem",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      &mdash; are less potent vasodilators and may primarily decrease the resistance at the efferent arteriole, similar to the ACE inhibitors. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Other antihypertensive drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to lowering the intraglomerular pressure, experimental studies suggest that the beneficial effect of ACE inhibitors may also be related to inhibition of other effects of angiotensin II, including glomerular hypertrophy and fibrosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Other actions of ACE inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/1\">",
"      Jacobson HR. Chronic renal failure: pathophysiology. Lancet 1991; 338:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/2\">",
"      Hollenberg NK, Raij L. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Arch Intern Med 1993; 153:2426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/3\">",
"      Yu HT. Progression of chronic renal failure. Arch Intern Med 2003; 163:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/4\">",
"      Brunner HR. ACE inhibitors in renal disease. Kidney Int 1992; 42:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/5\">",
"      Anderson S, Rennke HG, Garcia DL, Brenner BM. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989; 36:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/6\">",
"      Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH. The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994; 45:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/7\">",
"      Lee LK, Meyer TW, Pollock AS, Lovett DH. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995; 96:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/8\">",
"      Ichikawa I. Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int 1996; 50:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/9\">",
"      Lafayette RA, Mayer G, Park SK, Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/10\">",
"      Kakinuma Y, Kawamura T, Bills T, et al. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992; 42:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/11\">",
"      Zoja C, Donadelli R, Corna D, et al. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 1997; 29:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/12\">",
"      Ots M, Mackenzie HS, Troy JL, et al. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998; 9:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/13\">",
"      Zoja C, Corna D, Camozzi D, et al. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach. J Am Soc Nephrol 2002; 13:2898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/14\">",
"      Hutchison FN, Cui X, Webster SK. The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol 1995; 6:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/15\">",
"      Gon&ccedil;alves AR, Fujihara CK, Mattar AL, et al. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. Am J Physiol Renal Physiol 2004; 286:F945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/16\">",
"      Fujihara CK, Velho M, Malheiros DM, Zatz R. An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 2005; 67:1913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/17\">",
"      Bakris GL. The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states. J Am Soc Nephrol 1991; 2:S21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/18\">",
"      Griffin KA, Picken MM, Bidani AK. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 1995; 96:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/19\">",
"      Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993; 3:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/20\">",
"      Fogo AB. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis 2000; 35:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/21\">",
"      Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93:2431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/22\">",
"      Boffa JJ, Lu Y, Placier S, et al. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 2003; 14:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/23\">",
"      Shankland SJ, Ly H, Thai K, Scholey JW. Increased glomerular capillary pressure alters glomerular cytokine expression. Circ Res 1994; 75:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/24\">",
"      Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/25\">",
"      Remuzzi A, Gagliardini E, Donadoni C, et al. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 2002; 62:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/26\">",
"      Adamczak M, Gross ML, Krtil J, et al. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003; 14:2833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/27\">",
"      Ma L, Fogo AB. Role of angiotensin II in glomerular injury. Semin Nephrol 2001; 21:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/28\">",
"      Ma LJ, Nakamura S, Whitsitt JS, et al. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 2000; 58:2425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/29\">",
"      Remuzzi A, Puntorieri S, Battaglia C, et al. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990; 85:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13206/abstract/30\">",
"      Schanstra JP, Neau E, Drogoz P, et al. In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest 2002; 110:371.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7171 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-ED3CA7AB47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13206=[""].join("\n");
var outline_f12_57_13206=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2199613\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREFERENTIAL EFFECT OF ACE INHIBITORS ON RENAL HEMODYNAMICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Angiotensin receptor blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Other antihypertensive drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      OTHER ACTIONS OF ACE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      POSSIBLE ROLE OF ENDOTHELIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2199613\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7171\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7171|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/48/15117\" title=\"figure 1\">",
"      ACEI vs other drugs in DM rats",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/58/12207\" title=\"figure 2\">",
"      The effects of various therapies and treatment in diabetic dogs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35925?source=related_link\">",
"      Endothelin and the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=related_link\">",
"      Renal effects of ACE inhibitors in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=related_link\">",
"      Renin-angiotensin system inhibition in the treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26938?source=related_link\">",
"      Secondary factors and progression of chronic kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_57_13207="Actin signaling";
var content_f12_57_13207=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Pathomechanisms of proteinuria induced by GTPase dynamin cleavage by CatL",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 516px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schematic shows the connections between the cortical actin cytoskeleton and components of the basolateral portion of a podocyte. The membrane domains are marked: apical cell membrane (green); the SD domain (blue); and the \"sole\" of the foot process (pink). LPS injection into mice induces CatL expression in the cytoplasm, which cleaves the active form of GTPase dynamin (represented here in its GTP-bound homotetrameric form). Dynamin binds actin-regulatory proteins including cortactin and the Arp2/3 complex, which catalyze actin filament assembly. Cleavage of dynamin generates a 40-kDa dynamin fragment (p40), which interferes with the normal function of dynamin and induces cytoskeleton reorganization, foot process effacement, and proteinuria.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ronco, P. Proteinuria: is it all in the foot?. J Clin Invest 2007; 117:2079. Copyright &copy;2007 American Society for Clinical Investigation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13207=[""].join("\n");
var outline_f12_57_13207=null;
var title_f12_57_13208="Fixed drug eruption dark skin";
var content_f12_57_13208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    On dark skin, fixed drug eruption presents as a dark brown/slate-gray patch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13208=[""].join("\n");
var outline_f12_57_13208=null;
var title_f12_57_13209="Gallbladder polyps and cholesterolosis";
var content_f12_57_13209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gallbladder polyps and cholesterolosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Wisam F Zakko, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Salam F Zakko, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13209/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/57/13209/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallbladder polyps are outgrowths of the gallbladder mucosal wall. They are usually found incidentally on ultrasonography or after cholecystectomy. When detected on ultrasonography, their clinical significance relates largely to their malignant potential. The majority of these lesions are not neoplastic but are hyperplastic or represent lipid deposits (cholesterolosis). On the other hand, imaging studies alone are insufficiently specific to exclude the possibility of gallbladder carcinoma or premalignant adenomas. Furthermore, even benign lesions can occasionally lead to symptoms similar to those caused by gallbladder stones.",
"   </p>",
"   <p>",
"    While the widespread use of ultrasonography has made the diagnosis of polypoid lesions of the gallbladder increasingly frequent, optimal strategies for evaluating these lesions have not been established. This topic will review the clinical significance and differential diagnosis of gallbladder polyps, and will provide a practical approach to their management. Gallbladder cancer is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallbladder polyps have been observed in 0.004 to 13.8 percent of resected gallbladders [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/1\">",
"     1",
"    </a>",
"    ], and in 1.5 to 4.5 percent of gallbladders assessed by ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In one report, no association was observed between the presence of polyps and the patient's age, sex, weight, number of pregnancies, use of exogenous female hormones, or any other risk factors that are generally believed to be associated with gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/3\">",
"     3",
"    </a>",
"    ]. Gallbladder polyps have only rarely been described in children, in whom they occur either as a primary disorder or in association with other disorders, including metachromatic leukodystrophy, Peutz-Jeghers syndrome, or pancreatobiliary malunion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=see_link\">",
"     \"Epidemiology of and risk factors for gallstones\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classification of gallbladder polyps was first proposed in 1970 based upon a review of 180 benign tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/5\">",
"     5",
"    </a>",
"    ]. As a general rule, polypoid lesions can be categorized as benign or malignant (",
"    <a class=\"graphic graphic_table graphicRef56347 \" href=\"UTD.htm?39/17/40219\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Benign lesions have been further subdivided into neoplastic or non-neoplastic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common benign neoplastic lesion is an adenoma. Benign mesodermal tumors such as leiomyomas and lipomas are rare.",
"     </li>",
"     <li>",
"      The most common benign non-neoplastic lesions (pseudotumors) are cholesterol polyps (the presence of which is referred to as \"cholesterolosis\"), followed by adenomyomas (the presence of which is referred to as \"adenomyomatosis\"), and inflammatory polyps [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/1,5\">",
"       1,5",
"      </a>",
"      ]. Cholesterolosis and adenomyomatosis are mucosal abnormalities of the gallbladder. They have been referred to as \"hyperplastic cholecystoses\", a term introduced in 1960 to differentiate them from inflammatory conditions such as acute cholecystitis, since they lack inflammatory features but exhibit features of hyperplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/8\">",
"       8",
"      </a>",
"      ]. However, some data suggest that adenomyomatosis may be associated with an increased risk of gallbladder cancer. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Adenomyomatosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The most common malignant lesion in the gallbladder is adenocarcinoma. Gallbladder adenocarcinomas are much more common than gallbladder adenomas, in contrast to the colon where adenomas are much more common than adenocarcinomas. Squamous cell carcinomas, mucinous cystadenomas, and adenoacanthomas of the gallbladder are rare.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CHOLESTEROLOSIS AND CHOLESTEROL POLYPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholesterolosis has been recognized since 1857, when Virchow described it in a report on the role of the gallbladder in fat metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/9\">",
"     9",
"    </a>",
"    ]. Cholesterolosis is characterized by the accumulation of lipids in the mucosa of the gallbladder wall. It is a benign condition that is usually diagnosed incidentally during cholecystectomy or on ultrasonography. However, in some patients it can lead to symptoms and complications similar to those caused by gallstones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Epidemiology of cholesterolosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholesterolosis is common; its prevalence in surgical studies varies from 9 to 26 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/9\">",
"     9",
"    </a>",
"    ]. A large autopsy series of 1300 cases found the prevalence to be 12 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/10\">",
"     10",
"    </a>",
"    ]. Cholesterolosis in association with gallstones is by far the most common pathologic finding in the gallbladder [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/3\">",
"     3",
"    </a>",
"    ]. Most surgical series suggest risk factors that are similar to those for gallstone formation. However, as noted above, an ultrasound study showed no association with any of the known risk factors for gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Similarly, while gallstone disease is known to be more common in women, an autopsy series found the prevalence of cholesterolosis to be equal between men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/10\">",
"     10",
"    </a>",
"    ]. These contradictory observations may be explained by the observation that surgical series generally focus on gallbladders from patients who were symptomatic, which is not necessarily the case in autopsy or ultrasonographic studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathology of cholesterolosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholesterolosis results from abnormal deposits of triglycerides, cholesterol precursors, and cholesterol esters into the gallbladder mucosa. The lipid accumulation creates yellow deposits that are generally visible to the naked eye. The appearance of the yellow deposits on a background of hyperemic mucosa led to the description of this finding as a \"strawberry gallbladder\" (",
"    <a class=\"graphic graphic_picture graphicRef54904 \" href=\"UTD.htm?33/21/34130\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The main microscopic feature is the presence of fat laden macrophages within elongated villi. Most of the lipid in the cytoplasm of the macrophages is in the form of liquid crystals, which leads to birefringence under polarized light and gives a characteristic foamy appearance under microscopy (",
"    <a class=\"graphic graphic_picture graphicRef60481 \" href=\"UTD.htm?37/43/38582\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The hyperplastic villus is filled and distended with these cells, creating the small yellow nodules under the epithelium. In about two-thirds of cases, these nodules are less than 1 mm in diameter, which gives the mucosa the coarse and granular appearance that is characteristic of the diffuse or planar type of cholesterolosis. The nodules in the remaining one-third of cases are larger and polypoid in appearance (polypoid form) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the polypoid form the deposits give rise to solitary or multiple cholesterol polyps that are attached to the underlying mucosa with a fragile epithelial pedicle, the core of which is composed of lipid filled macrophages. These polyps can break off, leading to complications similar to those caused by small gallstones, such as biliary pain, pancreatitis, and obstructive jaundice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ADENOMYOMATOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomyomatosis is an abnormality of the gallbladder characterized by overgrowth of the mucosa, thickening of the muscle wall, and intramural diverticula. Despite the name, this condition does not involve any adenomatous changes in the gallbladder epithelium. While generally not considered to be a premalignant condition, adenomyomatosis is sometimes encountered in gallbladders resected for cancer, which has led to the suggestion that it is a premalignant condition [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/11\">",
"     11",
"    </a>",
"    ]. However, the association and its magnitude remain unclear. (See",
"    <a class=\"local\" href=\"#H2182460327\">",
"     'Adenomyomatosis and gallbladder cancer'",
"    </a>",
"    below.) There is, however, a clear association of adenomyomatosis with cholelithiasis, particularly with the segmental type, which was reported in 89 percent of patients with segmental adenomyomatosis in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Epidemiology of adenomyomatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomyomatosis of the gallbladder is less common than cholesterolosis in most reports [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/13\">",
"     13",
"    </a>",
"    ], with some exceptions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/14\">",
"     14",
"    </a>",
"    ]. In one report, for example, only 103 cases of adenomyomatosis were found in over 10,000 cholecystectomies (1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/13\">",
"     13",
"    </a>",
"    ]. This is compared to the much higher prevalence of cholesterolosis (9 to 26 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/9\">",
"     9",
"    </a>",
"    ]. Adenomyomatosis is more common in women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pathology of adenomyomatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The abnormality can be diffuse, segmental (annular), or localized to the fundus of the gallbladder.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diffuse adenomyomatosis causes thickening and irregularity of the mucosal surface and the muscle coat leading to cystic-like structures in the gallbladder wall or polypoid projections from the mucosa of the gallbladder. In the early phases, the intramural extension of the epithelium creates tubules and crypts in the lamina propria that accumulate mucous. Fluid filled mucosal pockets eventually herniate into the wall of the gallbladder and through the muscularis propria, forming cystic structures that are visible on gross inspection as pools of bile in the gallbladder wall (Rokitansky-Aschoff sinuses). The point of herniation may appear sealed due to hypertrophy of the muscularis.",
"     </li>",
"     <li>",
"      In the segmental type, a circumferential ring divides the gallbladder into separate interconnected compartments.",
"     </li>",
"     <li>",
"      In the localized type, the cystic structure forms a nodule, usually in the fundus, that projects into the lumen giving the appearance of a polyp on ultrasonography [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/11,14-16\">",
"       11,14-16",
"      </a>",
"      ]. The muscle layer in the involved area is usually thickened to three to five times its usual thickness [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/11,15\">",
"       11,15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2182460327\">",
"    <span class=\"h2\">",
"     Adenomyomatosis and gallbladder cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been several reports of gallbladder cancer arising in an area of segmental or fundal adenomyomatosis, but this association has not been a consistent finding in published series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 3197 consecutive, unselected cholecystectomies, gallbladder cancer developed in 6.4 percent of patients with segmental adenomyomatosis compared with 3.1 percent of all other cholecystectomies [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a similar retrospective series of 4560 patients, gallbladder cancer was identified in 6.6 percent of patients with segmental adenomyomatosis versus 4.3 percent in those without (p = 0.049) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      On the other hand, in a series of 4704 cholecystectomies, adenomyomatosis was found in 2.4 percent, but no cancer was identified in any of these patients' resected gallbladders [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 30 patients with adenomyomatosis of the gallbladder identified over seven years and comprising 3.3 percent of all cholecystectomies in that center, there were no cases of gallbladder cancer in any of these patients, but there was an association with gallstones [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 1099 patients who underwent cholecystectomy, adenomyomatosis was found in 14.2 percent with a strong association with gallstones but with no cases of cancer diagnosed [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One series suggested that gallbladder cancer in patients with adenomyomatosis may be associated with more advanced cancer; in a series of 97 patients with gallbladder cancer, 25 percent were positive for adenomyomatosis, and in these patients there was an increased risk for a more advanced T stage, lymph node, and distant metastasis. The authors suggested that the presence of adenomyomatosis may prevent early detection of gallbladder cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At this time, there is no conclusive evidence that the presence of adenomyomatosis increases the risk of gallbladder cancer. If the risk is increased, the magnitude of the increased risk appears to be small (probably not more than twice the average risk). Finally, there is evidence that the presence of adenomyomatosis is associated with more advanced gallbladder cancer, possibly because its presence prevents early diagnosis of cancer on imaging studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INFLAMMATORY POLYPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory polyps are the least common of the non-neoplastic polyps. They appear as either sessile or pedunculated on an ultrasonographic examination and are composed of granulation and fibrous tissue with plasma cells and lymphocytes. Polyps are usually 5 to 10 mm in diameter, although inflammatory polyps larger than 1 cm have been described. These large polyps can be confused with gallbladder carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ADENOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomatous polyps of the gallbladder are benign epithelial tumors that, unlike their colonic counterpart, are rare. Although the true incidence is unknown, in most series it is less than 0.5 percent. In one study, nine adenomatous polyps were identified among 2145 cholecystectomies (0.4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pathology of adenomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomas of the gallbladder are benign glandular tumors composed of cells resembling biliary tract epithelium. These lesions are classified into papillary and non-papillary types on histology [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/5\">",
"     5",
"    </a>",
"    ]. A classification similar to that of intestinal polyps has been proposed in which the adenomas are divided into tubular, papillary, and mixed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency that adenomas progress to adenocarcinoma is unknown. In a series from Japan, 18 patients with adenomas were identified among 1605 cholecystectomies. Of these, seven adenomas contained foci of carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/25\">",
"     25",
"    </a>",
"    ]. Similar to intestinal adenomas, the risk of malignancy is related to the size of the polyp. In the Japanese series, none of the polyps less than 12 mm contained foci of malignancy.",
"   </p>",
"   <p>",
"    In another review from 15 Japanese institutions, a 6 percent incidence of carcinoma was reported in lesions less than 1.0 cm, while the incidence was 37.5 percent in adenomas that were 1.0 to 2.0 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/26\">",
"     26",
"    </a>",
"    ]. In a third report in which nine adenomas were diagnosed among 2145 cholecystectomies, all of the nine polyps were less than 1 cm and none showed evidence for malignant changes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H15#H15\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'Molecular pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS POLYPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other benign neoplasms of the gallbladder, such as fibromas, lipomas, and leiomyomas, are extremely rare. The natural history of these polyps is not well defined, but is probably similar to their counterparts in other regions of the gastrointestinal tract.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps of the gallbladder are typically incidental findings detected during radiologic imaging of the abdomen. Their significance is related to their potential for malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Regardless of their type or etiology, gallbladder polyps can be associated with biliary pain. Proposed mechanisms of pain include prolapse of the polyp into Hartmann's pouch, which, if it occurs during gallbladder ejection, can lead to biliary-type pain that subsides upon spontaneous reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/27\">",
"     27",
"    </a>",
"    ]. Another possible mechanism is that a detached portion of a polyp lying free in the gallbladder lumen can obstruct the cystic duct in much the same way a gallstone would, leading to biliary colic or cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/28\">",
"     28",
"    </a>",
"    ]. The detached portion can also obstruct the common bile duct, leading to obstructive jaundice [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/29\">",
"     29",
"    </a>",
"    ] and pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a review of 3,797 cholecystectomies, 55 cases of gallbladder cholesterolosis without cholelithiasis were identified. Twenty-seven of these patients presented with recurrent attacks of acute pancreatitis, which disappeared after cholecystectomy. The gallbladders had frank cholesterolosis with a polypoid appearance. The authors postulated that detached cholesterol polyps temporarily impact at the sphincter of Oddi, leading to pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to biliary pain, cholesterolosis and adenomyomatosis have also been associated with chronic dyspeptic abdominal pain. In a study of 269 patients who underwent cholecystectomy and were found to have cholesterolosis, 96 percent had abdominal pain that was described as severe and in a majority, the pain had persisted for more than two years. Other symptoms reported in the same study were nausea and vomiting (61 percent) and dyspepsia (60 percent). Most of these symptoms resolved after cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/31\">",
"     31",
"    </a>",
"    ]. In another study, 35 of 55 patients with chronic abdominal pain underwent cholecystectomy; cholesterolosis was found in 20 patients, 19 of whom had improvement in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been suggested that polyps, cholesterolosis, and adenomyomatosis can lead to poor gallbladder emptying and compartmentalization that may be responsible for dyspeptic symptoms. However, the mechanism of these symptoms remains unclear since these observations have not been confirmed in other studies and the results of surgery are variable. Thus, it remains debatable whether these lesions can lead to chronic dyspeptic pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     RISK OF MALIGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most useful predictive feature for malignancy is the size of the polyp. Polyps larger than 2 cm are almost always malignant and, in many cases, the cancer is advanced. Polyps 1 to 2 cm in size should be regarded as possibly malignant. Several pathologic studies support this, with the incidence of carcinoma being 43 to 77 percent in polyps larger than 1 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/33\">",
"     33",
"    </a>",
"    ] and 100 percent in polyps larger than 2 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in diagnostic imaging have resulted in improved sensitivity for the detection of gallbladder polyps. Although none of the available modalities can reliably predict polyp type, histology, or the presence of malignancy, a combination of features seen on ultrasound, computed tomographic scan, and endoscopic ultrasound can provide valuable information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps are easily identified on ultrasonography as single or multiple echogenic foci. They can be easily differentiated from gallstones because they are fixed and do not move when the patient is rolled from one side to another. In addition, they do not cast a shadow (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70175 \" href=\"UTD.htm?41/14/42211\">",
"     image 1",
"    </a>",
"    ). A few small studies suggest that contrast-enhanced ultrasound, which uses microbubble contrast agents injected into the peripheral circulation to improve visualization, may facilitate the detection of polyps by helping to distinguish them from mural folds, gallbladder contents, or sludge [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have demonstrated that the use of Doppler ultrasound may also help differentiate benign lesions from primary gallbladder malignancies. These reports, which were mostly from Japan, demonstrated that the presence of color signal, the pattern of the signal, the resistive index, and particularly flow velocity help to identify primary malignancy of the gallbladder from benign lesions. In most of these studies, color Doppler was more useful than conventional abdominal ultrasound in diagnosing gallbladder lesions, mostly due to estimation of arterial flow velocity; however, there was overlap in velocities, and depending on the cut-off of the flow velocity used, it was not fully capable of identifying all malignant lesions, particularly early T1 lesions, perhaps related to low sensitivity in detecting fine blood flow in these lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/36-42\">",
"     36-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasonography can delineate other useful distinguishing characteristics in the appearance of polyps, including echogenicity, surface architecture, and the presence or absence of a pedicle.",
"   </p>",
"   <p>",
"    The following characteristics have been noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cholesterol polyps are usually multiple, homogeneous, and pedunculated polypoid lesions that are more echogenic than the liver parenchyma (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73242 \" href=\"UTD.htm?6/42/6819\">",
"       image 2",
"      </a>",
"      ). They may or may not contain hyperechoic spots and have a mulberry-like surface. Cholesterol polyps are usually smaller than 1 cm.",
"     </li>",
"     <li>",
"      Adenomas are homogeneous, are isoechoic with the liver parenchyma, have a smooth surface, and do not have a pedicle (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef71629 \" href=\"UTD.htm?11/44/11968\">",
"       image 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Adenocarcinomas are homogeneous, heterogeneous sessile, or mass-like polypoid structures that are usually isoechoic with the liver parenchyma and exhibit a mulberry-like surface [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      When located in the fundus, adenomyomatosis can produce a mucosal projection that can give the appearance of a polyp on ultrasonography (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80707 \" href=\"UTD.htm?35/31/36336\">",
"       image 4",
"      </a>",
"      ). These polypoid lesions are about 10 to 20 mm in diameter [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a report that used these criteria, preoperative ultrasonography correctly identified 89 percent of cholesterol polyps, 81 percent of malignant polyps, 50 percent of adenomas, and 0 percent of inflammatory polyps (",
"    <a class=\"graphic graphic_table graphicRef79560 \" href=\"UTD.htm?33/4/33867\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to cholesterol polyps, diffuse cholesterolosis has no specific ultrasonographic finding. As a result, the diagnosis is usually made during surgery.",
"   </p>",
"   <p>",
"    In patients with adenomyomatosis, ultrasonography shows non-specific focal thickening (&gt;4 mm) of the gallbladder wall. Careful examination may predict the presence of adenomyomatosis by revealing diffuse or segmental thickening with round anechoic foci that represent the intramural diverticula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Oral cholecystography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral cholecystography (OCG) has fallen out of favor since ultrasonography is much more sensitive and specific. OCG requires a functioning gallbladder and a patent cystic duct to visualize the gallbladder. Polyps appear as immobile filling defects which are usually difficult to differentiate from gallstones. Adenomyomatosis has a characteristic appearance of an invagination in the wall that may occasionally show Rokitansky-Aschoff sinuses (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80272 \" href=\"UTD.htm?4/54/4962\">",
"     image 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31722?source=see_link\">",
"     \"Uncomplicated gallstone disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is most useful in patients with gallbladder cancer since it can stage the disease by revealing liver invasion or metastasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are only limited data regarding the use of the CT scan in the evaluation of gallbladder polyps.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study noted 100 percent sensitivity of contrast enhanced CT for detecting gallbladder polyps in 20 patients who subsequently underwent cholecystectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/45\">",
"       45",
"      </a>",
"      ]. As in other studies, the size of the polyp was a predictor of malignancy. None of the six polyps less than 10 mm in diameter were neoplastic, while 5 of 14 polyps more than 10 mm in diameter were malignant and two were adenomas. Unenhanced CT detected four of five malignancies and both adenomas, whereas it missed all cholesterol and hyperplastic polyps. In addition, all cholesterol polyps were pedunculated, while most of the carcinomas were sessile (",
"      <a class=\"graphic graphic_table graphicRef50583 \" href=\"UTD.htm?30/13/30940\">",
"       table 3",
"      </a>",
"      ). The authors concluded that pedunculated polyps smaller than 10 mm in diameter that are seen only on enhanced CT are very likely to be cholesterol polyps.",
"     </li>",
"     <li>",
"      Similar results were noted in a more recent study involving 59 patients who underwent ultrasound and CT scanning prior to laparoscopic cholecystectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/46\">",
"       46",
"      </a>",
"      ]. In that study, 36 percent of cholesterol polyps were seen by ultrasound and not by CT.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A novel CT technique similar to CT colonography (\"virtual colonoscopy\") has been applied to the gallbladder. A pilot study suggested that it was more sensitive than standard CT and as sensitive as ultrasound for detecting gallbladder polyps [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/47\">",
"     47",
"    </a>",
"    ]. It was more accurate than ultrasound in characterizing the three dimensional structure of the polyps. A clinical role for this technique remains to be defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Endoscopic ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasonography (EUS) has the advantage of imaging the gallbladder through the gastric wall without deleterious attenuation by subcutaneous fat or interference from intestinal gas, which may limit the usefulness of conventional transabdominal ultrasonography. These benefits potentially make EUS a more accurate imaging modality for the gallbladder compared with transabdominal ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/48-53\">",
"     48-53",
"    </a>",
"    ]. However, EUS is not universally available and the data for its use in the differential diagnosis of gallbladder polyps are sparse.",
"   </p>",
"   <p>",
"    One retrospective study defined certain criteria for diagnosing cholesterol polyps, adenomyomatosis, and adenocarcinoma on EUS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/48\">",
"     48",
"    </a>",
"    ]. The presence of internal echo patterns characterized as tiny echogenic spots or an aggregation of multiple highly echogenic 1 to 3 mm spots with or without echopenic areas was considered diagnostic for cholesterol polyps. Adenomyomatosis (localized type) was diagnosed when there was a sessile echogenic mass containing multiple microcysts (corresponding to the dilated Rokitansky-Aschoff sinuses) or a comet tail artifact. In the absence of echogenic spots, multiple microcysts, or a comet tail artifact, the lesion was diagnosed as neoplastic (adenoma or adenocarcinoma).",
"   </p>",
"   <p>",
"    In a follow-up study by the same group using the same EUS criteria, a total of 194 patients with small (&lt;20 mm) polypoid lesions underwent both transabdominal ultrasonography and EUS. Fifty-eight of these patients underwent surgery either because of symptoms or a suspicion of a neoplastic lesion on EUS. Using these criteria, EUS correctly predicted the histology in 97 percent of the cases compared to 76 percent for transabdominal ultrasonography (",
"    <a class=\"graphic graphic_table graphicRef52861 \" href=\"UTD.htm?3/27/3516\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/49\">",
"     49",
"    </a>",
"    ]. In other reports, the investigators have relied on contour and internal echo patterns for differentiating neoplastic from non-neoplastic polyps [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Positron emission tomography (PET)",
"    </span>",
"    &nbsp;&mdash;&nbsp;When gallbladder cancer is suggested by ultrasound findings, FDG-PET can help establish if the lesion is benign or malignant. However, it cannot be relied upon to exclude malignancy when ultrasound is highly suggestive of a neoplastic polyp [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only effective treatment for gallbladder polyps or cholesterolosis is cholecystectomy, which should be considered in symptomatic patients or as prophylaxis to prevent malignant transformation. Optimal follow-up of patients who do not undergo cholecystectomy is unclear since there have been few studies and no controlled trials comparing cholecystectomy to observation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/55\">",
"     55",
"    </a>",
"    ]. However, a reasonable approach is suggested below.",
"   </p>",
"   <p>",
"    Although most gallbladder polyps are benign, the main objective is to exclude the presence of malignancy because advanced gallbladder cancer carries a poor prognosis and resection at an early stage offers the only hope for cure. What complicates matters is that none of the available imaging modalities can unequivocally distinguish neoplastic from non-neoplastic polyps. This can be achieved only by microscopic examination after surgery. Nevertheless, as discussed above, transabdominal ultrasonography and endoscopic ultrasonography can provide valuable information in the differential diagnosis of gallbladder polyps.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Polyps along with gallstones or primary sclerosing cholangitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have gallbladder polyps and concomitant gallstones should undergo cholecystectomy regardless of the polyp size or the presence of symptoms, since gallstones are a risk factor for gallbladder cancer in patients with gallbladder polyps [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/1,56,57\">",
"     1,56,57",
"    </a>",
"    ]. Gallbladder polyps arising in the setting of primary sclerosing cholangitis are frequently malignant and thus also warrant cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22521?source=see_link\">",
"     \"Clinical manifestations and diagnosis of primary sclerosing cholangitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H242993143\">",
"    <span class=\"h2\">",
"     Adenomyomatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on case reports and retrospective series that suggest a possible increased risk of gallbladder cancer in patients with adenomyomatosis, some authors recommend considering cholecystectomy for patients with adenomyomatosis. However, as shown above, the association between gallbladder malignancy and adenomyomatosis remains unclear. (See",
"    <a class=\"local\" href=\"#H2182460327\">",
"     'Adenomyomatosis and gallbladder cancer'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Furthermore, even if there is an increased risk of gallbladder cancer, the absolute risk for an individual patient remains small. Given the uncertainty and apparent small risk, we do not recommend cholecystectomy for patients with asymptomatic adenomyomatosis. While we do not have enough data to make preoperative predictions of which patients are at increased risk for cancer based on ultrasound or other imaging modalities, it should be kept in mind that the presence of adenomyomatosis may obscure an underlying cancer. In cases where there is concern that adenomyomatosis may be obscuring a malignancy, cholecystectomy is a reasonable alternative in patients who are fit for surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholecystectomy is recommended for patients who have biliary colic or pancreatitis, since an appreciable proportion of such patients with cholesterolosis or adenomyomatosis improve after cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/29,31,32,60\">",
"     29,31,32,60",
"    </a>",
"    ]. On the other hand, patients with non-specific dyspeptic symptoms but without symptoms consistent with biliary colic should be managed conservatively (unless other indications for polyp removal are present) since the pathogenesis of these symptoms is unclear and cholecystectomy may not relieve the symptoms. Such patients should be treated symptomatically, as are other patients with chronic functional dyspepsia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27720?source=see_link\">",
"     \"Approach to the patient with dyspepsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for patients who do not fall into any of the above categories depend upon the size of the polyps (",
"    <a class=\"graphic graphic_algorithm graphicRef73510 \" href=\"UTD.htm?16/40/17039\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Lesions larger than 18 to 20 mm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lesions larger than 18 to 20 mm are usually malignant and should be resected. Because these lesions may represent advanced cancer, patients should undergo preoperative staging with a computed tomographic (CT) scan and endoscopic ultrasound. An extended cholecystectomy with lymph node dissection and partial hepatic resection in the gallbladder bed is required when performing cholecystectomy for malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Lesions from 10 to 20 mm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps 10 to 20 mm in diameter should be regarded as possibly malignant. Cancer of this size is usually at an early stage and laparoscopic cholecystectomy with full thickness dissection (removal of the entire connective tissue layers of the gallbladder bed to expose the liver surface) is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/43,60\">",
"     43,60",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Risk of malignancy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Lesions from 5 to 10 mm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lesions 5 to 10 mm in diameter may represent cholesterol polyps, adenomas, or carcinomas. Multiple polyps, pedunculated polyps, and those that are hyperechoic compared with the liver are usually cholesterol polyps, while solitary and sessile polyps that are isoechoic with the liver are more likely to be neoplastic (see above).",
"   </p>",
"   <p>",
"    The most reassuring finding is the stability of a polyp on repeated follow-up examinations, though there is no consensus regarding the frequency of follow-up ultrasounds. One group recommends follow-up ultrasounds of polyps 5 to 10 mm in diameter at three months, six months, and then yearly [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/33,61\">",
"     33,61",
"    </a>",
"    ], whereas the American Society for Gastrointestinal Endoscopy recommends follow-up ultrasounds yearly [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/60\">",
"     60",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The need for follow-up was demonstrated in a study of 1027 patients with gallbladder polyps who were followed for more than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/62\">",
"     62",
"    </a>",
"    ]. An increase in polyp size was noted in 36 patients (3.5 percent), of which nine (0.8 percent) were neoplastic (defined as either malignant or premalignant). Of those nine polyps, six were less than 10 mm in size prior to the start of follow-up.",
"   </p>",
"   <p>",
"    We suggest that patients be followed yearly. Surgery is indicated in patients with an increase in polyp size.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Lesions smaller than 5 mm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps smaller than 5 mm are usually benign and most frequently represent cholesterolosis. Asymptomatic patients with cholesterol polyps do not need treatment. However, a repeat ultrasound examination in 6 and 12 months may be appropriate. Follow-up examinations are not necessary if the polyp is stable. Medical management aimed at increasing the solubility of cholesterol in bile by administering",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"     ursodeoxycholic acid",
"    </a>",
"    is without benefit in patients with cholesterolosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13209/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polypoid lesions in the gallbladder can be categorized as benign or malignant (",
"      <a class=\"graphic graphic_table graphicRef56347 \" href=\"UTD.htm?39/17/40219\">",
"       table 1",
"      </a>",
"      ). Benign lesions are further subdivided into neoplastic (adenomas, leiomyomas, lipomas) or non-neoplastic (cholesterol polyps, inflammatory polyps). Adenomyomas may be associated with gallbladder cancer, so whether they are neoplastic or non-neoplastic lesions is not clear. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cholesterolosis results from abnormal deposits of triglycerides, cholesterol precursors, and cholesterol esters into the gallbladder mucosa. In about two-thirds of cases, these nodules are less than 1 mm in diameter. The nodules in the remaining one-third of cases are larger and polypoid in appearance (polypoid form). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Cholesterolosis and cholesterol polyps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Polyps of the gallbladder are typically incidental findings detected during radiologic imaging of the abdomen. Their significance is related to their potential for malignancy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Advances in diagnostic imaging have resulted in improved sensitivity for the detection of gallbladder polyps. Although none of the available modalities can reliably and unequivocally predict the type, histology, or the presence of malignancy, a combination of features seen on ultrasound, computed tomography, and endoscopic ultrasonograph can provide valuable information. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The only effective treatment for gallbladder polyps or cholesterolosis is cholecystectomy, which should be considered in symptomatic patients or as prophylaxis to prevent malignant transformation in some settings. We suggest cholecystectomy for patients with gallbladder polyps who also have gallstones, primary sclerosing cholangitis, biliary colic, or pancreatitis. Recommendations for patients who do not fit into these categories depend upon the size of the polyps (",
"      <a class=\"graphic graphic_algorithm graphicRef73510 \" href=\"UTD.htm?16/40/17039\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/1\">",
"      Yang HL, Sun YG, Wang Z. Polypoid lesions of the gallbladder: diagnosis and indications for surgery. Br J Surg 1992; 79:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/2\">",
"      Heyder N, G&uuml;nter E, Giedl J, et al. [Polypoid lesions of the gallbladder]. Dtsch Med Wochenschr 1990; 115:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/3\">",
"      J&oslash;rgensen T, Jensen KH. Polyps in the gallbladder. A prevalence study. Scand J Gastroenterol 1990; 25:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/4\">",
"      Stringer MD, Ceylan H, Ward K, Wyatt JI. Gallbladder polyps in children--classification and management. J Pediatr Surg 2003; 38:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/5\">",
"      Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol 1970; 90:423.",
"     </a>",
"    </li>",
"    <li>",
"     Weedon D. Benign mucosal polyps. In: Pathology of the gallbladder, Mason, New York 1984. p.195.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/7\">",
"      Laitio M. Histogenesis of epithelial neoplasms of human gallbladder II. Classification of carcinoma on the basis of morphological features. Pathol Res Pract 1983; 178:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/8\">",
"      JUTRAS JA. Hyperplastic cholecystoses; Hickey lecture, 1960. Am J Roentgenol Radium Ther Nucl Med 1960; 83:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/9\">",
"      SALMENKIVI K. CHOLESTEROSIS OF THE GALL-BLADDER. A CLINICAL STUDY BASED ON 269 CHOLECYSTECTOMIES. Acta Chir Scand Suppl 1964; 105:SUPPL 324:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/10\">",
"      FELDMAN M, FELDMAN M Jr. Cholesterosis of the gallbladder; an autopsy study of 165 cases. Gastroenterology 1954; 27:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/11\">",
"      Maccarty WC. IV. The Pathology of the Gall-bladder and some Associated Lesions: A Study of Specimens from 365 Cholecystectomies. Ann Surg 1910; 51:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/12\">",
"      Nishimura A, Shirai Y, Hatakeyama K. Segmental adenomyomatosis of the gallbladder predisposes to cholecystolithiasis. J Hepatobiliary Pancreat Surg 2004; 11:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/13\">",
"      Shepard VD, Walters W, Dockerty MB. Benign neoplasms of the gallbladder. Arch Surg 1942; 45:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/14\">",
"      Jutras JA, Levesque HP. Adenomyoma and adenomyomatosis of the gallbladder, radiologic and pathologic correlations. Rad Clin N Amer 1966; 4:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/15\">",
"      BEAN BC, BERENS DL, CULVER GJ. The relationship of stenosis to Rokitansky Aschoff sinuses of the gallbladder. Am J Roentgenol Radium Ther Nucl Med 1957; 77:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/16\">",
"      King ES, McCallum P. Cholecystitis glandularis Proliferans. Br J Surg 1931; 19:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/17\">",
"      Ootani T, Shirai Y, Tsukada K, Muto T. Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 1992; 69:2647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/18\">",
"      Nabatame N, Shirai Y, Nishimura A, et al. High risk of gallbladder carcinoma in elderly patients with segmental adenomyomatosis of the gallbladder. J Exp Clin Cancer Res 2004; 23:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/19\">",
"      Kim JH, Jeong IH, Han JH, et al. Clinical/pathological analysis of gallbladder adenomyomatosis; type and pathogenesis. Hepatogastroenterology 2010; 57:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/20\">",
"      Kasahara Y, Sonobe N, Tomiyoshi H, et al. Adenomyomatosis of the gallbladder: a clinical survey of 30 surgically treated patients. Nihon Geka Hokan 1992; 61:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/21\">",
"      Kai K, Ide T, Masuda M, et al. Clinicopathologic features of advanced gallbladder cancer associated with adenomyomatosis. Virchows Arch 2011; 459:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/22\">",
"      Maeyama R, Yamaguchi K, Noshiro H, et al. A large inflammatory polyp of the gallbladder masquerading as gallbladder carcinoma. J Gastroenterol 1998; 33:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/23\">",
"      Farinon AM, Pacella A, Cetta F, Sianesi M. \"Adenomatous polyps of the gallbladder\" adenomas of the gallbladder. HPB Surg 1991; 3:251.",
"     </a>",
"    </li>",
"    <li>",
"     Albores-Saaverdra J, Henson DE. Tumors of the gallbladder and the extrahepatic bile duct, 17-25. US Armed Forces Institute of Pathology, Washington, DC 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/25\">",
"      Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer 1982; 50:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/26\">",
"      [Collective review of 503 cases of small polypoid lesions (less than 20mm in maximum diameter) of the gallbladder: size distribution in various diseases and the depth of carcinomatous invasion]. Nihon Shokakibyo Gakkai Zasshi 1986; 83:2086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/27\">",
"      McGregor JC, Cordiner JW. Papilloma of the gallbladder. Br J Surg 1974; 61:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/28\">",
"      KANE CF, BROWN CH, HOERR SO. Papilloma of the gallbladder; report of eight cases. Am J Surg 1952; 83:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/29\">",
"      Takii Y, Shirai Y, Kanehara H, Hatakeyama K. Obstructive jaundice caused by a cholesterol polyp of the gallbladder: report of a case. Surg Today 1994; 24:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/30\">",
"      Parrilla Paricio P, Garc&iacute;a Olmo D, Pellicer Franco E, et al. Gallbladder cholesterolosis: an aetiological factor in acute pancreatitis of uncertain origin. Br J Surg 1990; 77:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/31\">",
"      MITTY WF Jr, ROUSSELOT LM. Cholesterosis of the gall bladder. Gastroenterology 1957; 32:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/32\">",
"      Kmiot WA, Perry EP, Donovan IA, et al. Cholesterolosis in patients with chronic acalculous biliary pain. Br J Surg 1994; 81:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/33\">",
"      Koga A, Watanabe K, Fukuyama T, et al. Diagnosis and operative indications for polypoid lesions of the gallbladder. Arch Surg 1988; 123:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/34\">",
"      Ishikawa O, Ohhigashi H, Imaoka S, et al. The difference in malignancy between pedunculated and sessile polypoid lesions of the gallbladder. Am J Gastroenterol 1989; 84:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/35\">",
"      Meacock LM, Sellars ME, Sidhu PS. Evaluation of gallbladder and biliary duct disease using microbubble contrast-enhanced ultrasound. Br J Radiol 2010; 83:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/36\">",
"      Li D, Dong BW, Wu YL, Yan K. Image-directed and color Doppler studies of gallbladder tumors. J Clin Ultrasound 1994; 22:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/37\">",
"      Hirooka Y, Naitoh Y, Goto H, et al. Differential diagnosis of gall-bladder masses using colour Doppler ultrasonography. J Gastroenterol Hepatol 1996; 11:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/38\">",
"      Li D. [Color Doppler flow imaging in gallbladder tumors]. Zhonghua Yi Xue Za Zhi 1992; 72:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/39\">",
"      Pradhan S, Shukla VK, Agrawal S, et al. Sonographic and colour doppler morphology in carcinoma gallbladder. Indian J Cancer 2002; 39:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/40\">",
"      Sato M, Ishida H, Konno K, et al. Localized gallbladder carcinoma: sonographic findings. Abdom Imaging 2001; 26:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/41\">",
"      Komatsuda T, Ishida H, Konno K, et al. Gallbladder carcinoma: color Doppler sonography. Abdom Imaging 2000; 25:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/42\">",
"      Hayakawa S, Goto H, Hirooka Y, et al. Colour Doppler-guided spectral analysis of gall-bladder wall flow. J Gastroenterol Hepatol 1998; 13:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/43\">",
"      Kubota K, Bandai Y, Noie T, et al. How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery 1995; 117:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/44\">",
"      Berk RN, van der Vegt JH, Lichtenstein JE. The hyperplastic cholecystoses: cholesterolosis and adenomyomatosis. Radiology 1983; 146:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/45\">",
"      Furukawa H, Takayasu K, Mukai K, et al. CT evaluation of small polypoid lesions of the gallbladder. Hepatogastroenterology 1995; 42:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/46\">",
"      Choi JH, Yun JW, Kim YS, et al. Pre-operative predictive factors for gallbladder cholesterol polyps using conventional diagnostic imaging. World J Gastroenterol 2008; 14:6831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/47\">",
"      Lou MW, Hu WD, Fan Y, et al. CT biliary cystoscopy of gallbladder polyps. World J Gastroenterol 2004; 10:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/48\">",
"      Sugiyama M, Xie XY, Atomi Y, Saito M. Differential diagnosis of small polypoid lesions of the gallbladder: the value of endoscopic ultrasonography. Ann Surg 1999; 229:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/49\">",
"      Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gall bladder lesions: analysis in surgical and follow up series. Gut 2000; 46:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/50\">",
"      Kimura K. [Diagnosis for pedunculated polypoid lesions of the gallbladder by endoscopic ultrasonography]. Nihon Shokakibyo Gakkai Zasshi 1997; 94:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/51\">",
"      Matsumoto J. Endoscopic ultrasonography diagnosis of gallbladder lesions. Endoscopy 1998; 30 Suppl 1:A124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/52\">",
"      Azuma T, Yoshikawa T, Araida T, Takasaki K. Differential diagnosis of polypoid lesions of the gallbladder by endoscopic ultrasonography. Am J Surg 2001; 181:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/53\">",
"      Muguruma N, Okamura S, Ichikawa S, et al. Endoscopic sonography in the diagnosis of gallbladder wall lesions in patients with gallstones. J Clin Ultrasound 2001; 29:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/54\">",
"      Rodr&iacute;guez-Fern&aacute;ndez A, G&oacute;mez-R&iacute;o M, Medina-Ben&iacute;tez A, et al. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol 2006; 93:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/55\">",
"      Gurusamy KS, Abu-Amara M, Farouk M, Davidson BR. Cholecystectomy for gallbladder polyp. Cochrane Database Syst Rev 2009; :CD007052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/56\">",
"      Pati&ntilde;o JF, Quintero GA. Asymptomatic cholelithiasis revisited. World J Surg 1998; 22:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/57\">",
"      Terzi C, S&ouml;kmen S, Se&ccedil;kin S, et al. Polypoid lesions of the gallbladder: report of 100 cases with special reference to operative indications. Surgery 2000; 127:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/58\">",
"      Buckles DC, Lindor KD, Larusso NF, et al. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am J Gastroenterol 2002; 97:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/59\">",
"      Schramm C, Lohse AW. Gallbladder polyps in primary sclerosing cholangitis: Indication for early intervention. Hepatology 2012; 56:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/60\">",
"      ASGE Standards of Practice Committee, Anderson MA, Appalaneni V, et al. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. Gastrointest Endosc 2013; 77:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/61\">",
"      Koga A, Yamauchi S, Nakayama F. Primary carcinoma of the gallbladder. Am Surg 1985; 51:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/62\">",
"      Park JY, Hong SP, Kim YJ, et al. Long-term follow up of gallbladder polyps. J Gastroenterol Hepatol 2009; 24:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13209/abstract/63\">",
"      Yamamoto T. [A study of cholesterol gallstone formation in cases of cholesterolosis of the gallbladder (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1979; 76:91.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 646 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-89ED0DCEDC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13209=[""].join("\n");
var outline_f12_57_13209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CHOLESTEROLOSIS AND CHOLESTEROL POLYPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Epidemiology of cholesterolosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathology of cholesterolosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ADENOMYOMATOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Epidemiology of adenomyomatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pathology of adenomyomatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2182460327\">",
"      Adenomyomatosis and gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INFLAMMATORY POLYPS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ADENOMAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pathology of adenomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MISCELLANEOUS POLYPS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      RISK OF MALIGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Oral cholecystography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Endoscopic ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Positron emission tomography (PET)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Polyps along with gallstones or primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H242993143\">",
"      Adenomyomatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Lesions larger than 18 to 20 mm",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Lesions from 10 to 20 mm",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Lesions from 5 to 10 mm",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Lesions smaller than 5 mm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/646\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/646|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?16/40/17039\" title=\"algorithm 1\">",
"      Algorithm gallbladder polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/646|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/14/42211\" title=\"diagnostic image 1\">",
"      Gallbladder polyp vs stone US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/42/6819\" title=\"diagnostic image 2\">",
"      GB cholesterolosis US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/44/11968\" title=\"diagnostic image 3\">",
"      GB adenomatous polyp US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/31/36336\" title=\"diagnostic image 4\">",
"      Gallbladder adenomyomatosis US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/54/4962\" title=\"diagnostic image 5\">",
"      GB adenomyomatosis OCG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/646|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/21/34130\" title=\"picture 1\">",
"      Strawberry gallbladder Gross",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/43/38582\" title=\"picture 2\">",
"      GB cholesterolosis Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/646|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/17/40219\" title=\"table 1\">",
"      Frequency gallbladder polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/4/33867\" title=\"table 2\">",
"      Accuracy US-gallbladder polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/13/30940\" title=\"table 3\">",
"      CT for gallbladder polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/27/3516\" title=\"table 4\">",
"      EUS gallbladder polyps",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27720?source=related_link\">",
"      Approach to the patient with dyspepsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22521?source=related_link\">",
"      Clinical manifestations and diagnosis of primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=related_link\">",
"      Epidemiology of and risk factors for gallstones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31722?source=related_link\">",
"      Uncomplicated gallstone disease in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_57_13210="Intrauterine fetal transfusion of red blood cells";
var content_f12_57_13210=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intrauterine fetal transfusion of red blood cells",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13210/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13210/contributors\">",
"     Kenneth J Moise Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13210/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13210/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/57/13210/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/57/13210/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/57/13210/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The infusion of red blood cells (RBCs) into the fetus is one of the most successful means of in utero therapy. Although never studied in randomized trials, there is no doubt that this technique has contributed to survival of the severely anemic fetus. Universal use of Rh(D) immune globulin has dramatically reduced the need for intrauterine transfusion; however, the procedure continues to be an essential modality for treatment of severe fetal anemia from a variety of causes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sir William Liley first introduced the concept of intrauterine transfusion (IUT). While working in New Zealand, he learned from a visiting fellow that RBCs infused into the peritoneal cavity of African children with sickle cell disease appeared to migrate into the intravascular space and correct their anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/1\">",
"     1",
"    </a>",
"    ]. Liley postulated that peritoneal infusion (IPT) of RBCs could also be used to transfuse the severely anemic fetus. Since ultrasonography was not yet available, these early procedures were 'guided' by radiographs or fluoroscopy. Fetal position was determined by a variety of techniques, such as using radiopaque dyes to delineate fetal bowel, placing metal markers on the maternal abdomen to indicate fetal position, and inserting needles to immobilize the fetus.",
"   </p>",
"   <p>",
"    Static gray scale ultrasonography was first used in conjunction with IUT in 1975, and replaced by real-time ultrasonography in 1977. The next major advance was in 1981 when an intravascular transfusion (IVT) was performed by inserting the transfusion needle directly into a fetal vessel on the placental plate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/2\">",
"     2",
"    </a>",
"    ]. Currently, the standard method of fetal transfusion uses an umbilical vessel or the intrahepatic portion of the umbilical vein for direct access to the fetal vasculature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92167028\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrauterine transfusion of RBCs is indicated to prevent fetal death from severe anemia. The procedure is generally limited to fetuses between 18 and 35 weeks of gestation because of technical limitations before 18 weeks and excessive fetal risk compared with delivery and postnatal transfusion after 35 weeks (see",
"    <a class=\"local\" href=\"#H24\">",
"     'Gestational age at first transfusion'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Normal fetal hemoglobin concentration increases linearly during pregnancy, from about 10 to 11",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    at 17 weeks to about 14 to 15",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    at term, one standard deviation is approximately 1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef53399 \" href=\"UTD.htm?24/53/25436\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Severe fetal anemia has been defined in a variety of ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemoglobin level &gt;7",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      below the normal mean for gestational age [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hemoglobin level &lt;5.8 to 7.4",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      depending on gestational age. In this study, 12 of 31 fetuses with severe anemia were hydropic and all 12 had hemoglobin values less than 5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hemoglobin level two standard deviations below the mean value for gestational age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We initiate transfusion when the fetal hemoglobin falls two standard deviations below the mean value for gestational age. At this level of anemia, intervention is better tolerated and with improved rates of survival than when attempted in more severely anemic hydropic fetuses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92167051\">",
"    <span class=\"h2\">",
"     Causes of severe fetal anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of severe fetal anemia are red cell alloimmunization, parvovirus infection, chronic fetomaternal hemorrhage, inherited red cell disorders, and complications of treatment for twin-twin transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Red cell alloimmunization",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 50 antibodies against red cell antigens have been associated with hemolytic disease of the",
"    <span class=\"nowrap\">",
"     fetus/newborn.",
"    </span>",
"    Among fetuses with erythroblastosis fetalis requiring IUTs, the most common antibodies are anti-D, anti-K1 (Kell), and anti&ndash;c. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32982?source=see_link\">",
"     \"Overview of Rhesus (Rh) alloimmunization in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/27/3513?source=see_link\">",
"     \"Significance of minor red blood cell antibodies during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Parvovirus infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal anemia related to parvovirus infection is due to arrest of maturation of bone marrow precursors. Hydrops in these fetuses can be due to heart failure secondary to the resulting high output state",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to myocarditis. The utility of fetal transfusion for this indication is supported by pooled data showing that 188 of 230 (82 percent) of transfused fetuses had a normal outcome as compared to 239 of 435 (55 percent) of those treated conservatively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/29/40408?source=see_link\">",
"     \"Parvovirus B19 infection during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Chronic fetomaternal hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic fetomaternal hemorrhage (FMH) can lead to fetal anemia. When severe, these pregnancies present clinically because of decreased or absent fetal movement. The fetal heart rate may be sinusoidal and ultrasound examination often reveals hydrops. A Kleihauer-Betke test, or other technique for detection of fetal blood in the maternal circulation, is needed to confirm the diagnosis. In pregnancies remote from term, data from case reports and small series suggest that IUT can improve fetal survival. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/45/3800?source=see_link\">",
"     \"Diagnosis and management of massive fetomaternal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Inherited RBC disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;IUT has also been used to treat severe fetal anemia due to alpha thalassemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/7-10\">",
"     7-10",
"    </a>",
"    ] and congenital dyserythropoietic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/11\">",
"     11",
"    </a>",
"    ]. Long-term survival in such cases depends upon neonatal red cell transfusions and subsequent bone marrow transplantation. A single case of fetal xerocytosis has been reported with resolution of hydrops fetalis and a normal neonatal course [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=see_link\">",
"     \"Anemia in children due to decreased red blood cell production\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Complications after treatment of twin-twin transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetoscopic laser ablation for treatment of twin-twin transfusion may be complicated by acute death of one twin and severe anemia in the other twin. In one series, IUT of the anemic fetus resulted in a healthy survivor in 11 of 19 cases (58 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/13\">",
"     13",
"    </a>",
"    ]. Chronic twin anemia-polycythemia syndrome after laser therapy has also been successfully treated with serial IUTs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9913?source=see_link\">",
"     \"Management of twin-twin transfusion syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     BLOOD FOR TRANSFUSION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;RBCs used for IUT must undergo the same testing that occurs for any red cell donor unit. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=see_link\">",
"     \"Laboratory testing of donated blood\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional requirements specific to IUT include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type O Rh(D) negative RBCs are transfused.",
"     </li>",
"     <li>",
"      Donor units are screened for antibody to cytomegalovirus (CMV); the units must be negative.",
"     </li>",
"     <li>",
"      The donation should be relatively fresh to enhance the level of 2-3-diphosphoglycerate (DPG). In the United Kingdom, this means that red cells used for IUT should not have been stored more than five days.",
"     </li>",
"     <li>",
"      British Blood Transfusion Task Force [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/15\">",
"       15",
"      </a>",
"      ] and AABB (formerly the American Association of Blood Banks) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/16\">",
"       16",
"      </a>",
"      ] standards require that red cell units for IUT undergo irradiation with 25 Gy of gamma radiation to the central portion of the donor bag to prevent a graft-versus-host reaction.",
"     </li>",
"     <li>",
"      Leukodepletion is a requirement in the United Kingdom, but not routinely done in the United States. However, it is often used to reduce CMV risk and will likely be universally accepted in the United States in the near future.",
"     </li>",
"     <li>",
"      Units are washed and tightly packed to a final hematocrit of 75 to 85 percent to reduce the volume administered to the fetus at the time of IUT. (By comparison, the hematocrit of a unit of RBCs used for transfusion of adults is approximately 65 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies of women undergoing IUT have observed that about 25 percent produce additional RBC antibodies due to exposure to antigens on donor blood and paternal antigens on fetal blood that are foreign to the mother [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. The risk is highest when the IUT necessitates passing a needle through the placenta. Matching donor and recipient units for D, C, c, E, e, and K antigens does not reduce the risk of new antibody formation, as differences in other minor antigens still exist [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Autologous donation by the pregnant patient can be considered as a source of red cells for IUT, as use of maternal RBCs for IUT eliminates the mother's risk of becoming sensitized to donor RBC antigens. However, all of the prerequisites for autologous donation must be met and the requirement for a predonation hemoglobin above 12.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    will exclude many pregnant patients as potential donors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=see_link\">",
"     \"Preoperative autologous blood donation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A potential fetal advantage of maternal donation is that the RBCs may have a longer half-life, which would decrease the total number of IUTs necessary for treatment. A study comparing 76 IUTs in which maternal blood was used to 213 IUTs in which donor red cells were used reported the rate of decline of the fetal hematocrit between IUT procedures was significantly slower in fetuses that received maternal blood, although this difference was not evident until after 33 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/20\">",
"     20",
"    </a>",
"    ]. In addition, neonates that received maternal blood required fewer transfusions than neonates whose transfusion came from other donors. The authors hypothesized that the lower transfusion requirements were related to use of blood with a high proportion of young cells (with a longer half life) as a result of increased maternal reticulocytosis after repeated maternal donations.",
"   </p>",
"   <p>",
"    The risk of transmission of blood-borne viral infections may be lower if maternal blood is used for transfusion, but this has not been studied.",
"   </p>",
"   <p>",
"    Pregnant women who donate blood should consume a daily prenatal vitamin, as well as supplemental iron (325 mg",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/11/37046?source=see_link\">",
"     ferrous sulfate",
"    </a>",
"    twice daily) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    (1 mg daily). The donated unit can be separated into two smaller aliquots and refrigerated for up to 42 days; however, this compromises freshness. If the blood is not used by this date, it can be frozen for use up to 10 years later.",
"   </p>",
"   <p>",
"    Additional considerations related to pregnancy include positioning the women in the left lateral recumbent position during the donation, replacing the donated volume with isotonic intravenous fluids, and additional processing (blood is washed several times to remove the offending antibody). Fetal monitoring during the procedure is unnecessary. A standard volume of 450",
"    <span class=\"nowrap\">",
"     +/-",
"    </span>",
"    45 mLs is taken, as subsequent washing and packing will markedly reduce the final volume available for IUT.",
"   </p>",
"   <p>",
"    Since the mother and fetus share HLA antigens at many loci, the possibility of graft-versus-host disease (GVHD) is higher than with use of an unrelated donor unit where HLA mismatch enables the recipient's immune system to destroy the donor lymphocytes. To avoid transfusion-associated GVHD, the unit should be leukoreduced using specialized filters, in addition to the standard irradiation protocol.",
"   </p>",
"   <p>",
"    The use of maternal blood in the CMV seropositive mother is controversial since dormant CMV virus can reside in polymorphonuclear leukocytes. Both leukoreduction and washing are effective mechanisms for preventing the transmission of CMV. For this reason, the risks and benefits of use of CMV seropositive maternal blood should be discussed with the patient in consultation with the blood bank service.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CHOICE OF ACCESS SITE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The various methods and points of access for IUT have not been compared in randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/21\">",
"     21",
"    </a>",
"    ]. For this reason, many centers have developed their own preference for a specific methodology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Peritoneal cavity",
"    </span>",
"    &nbsp;&mdash;&nbsp;IPT provides indirect access to the fetal circulation. It utilizes the principle that fluid and cells in the peritoneal cavity are absorbed through the diaphragmatic lymphatics. In the hydropic fetus, however, a functional blockage of the lymphatic system probably exists and prevents good absorption of RBCs after IPT. Thus, the procedure is least effective in those fetuses who are most severely anemic and in need of treatment. This was best illustrated in a study of hydropic and nonhydropic fetuses matched for severity of disease, placental location, and gestational age at the first transfusion that compared outcomes with IPT and IVT [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/22\">",
"     22",
"    </a>",
"    ]. Compared to IPT, IVT improved survival almost two-fold in hydropic fetuses and by 13 percent in nonhydropic fetuses. No randomized trials comparing these techniques have been performed.",
"   </p>",
"   <p>",
"    Given the higher rate of survival with IVT, it is the preferred method for transfusing the anemic fetus. However, IPT remains a viable option when fetal vascular access is difficult because of early gestational age or fetal position [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Direct vascular access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravascular transfusion (IVT) is generally preferred to intraperitoneal transfusion (IPT) because IVT is significantly more effective in hydropic fetuses and the effects of transfusion are more rapid [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/22,24-26\">",
"     22,24-26",
"    </a>",
"    ]. For direct intravascular access, North American centers typically target the umbilical vein at the placental end of the cord insertion, while many European centers utilize the intrahepatic portion of the umbilical vein.",
"   </p>",
"   <p>",
"    Direct cardiac puncture is another approach; however, it has been associated with a higher rate of fetal death (8 percent versus &lt;3 percent per procedure with use of the umbilical vein) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/27\">",
"     27",
"    </a>",
"    ]. This technique should probably be reserved for rare cases when access to the umbilical cord insertion or intrahepatic portion of the umbilical vein is not possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Umbilical cord",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal site for umbilical cord puncture is into the umbilical vein in the portion of cord near its insertion into the placenta. Puncture of the umbilical artery, a free-floating middle segment of cord, or the cord insertion proximate to the fetal umbilicus is less desirable because manipulation of these sites is associated with a higher rate of fetal bradycardia than the placental insertion site [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The higher incidence of bradycardia with umbilical artery puncture (21 versus 3 percent) is probably due to spasm of the muscularis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The cord proximate to the fetal umbilicus appears to have vagal innervation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/30\">",
"     30",
"    </a>",
"    ], which might account for the increased the risk of fetal bradycardia. Free-floating midsegments of the umbilical cord have the additional problem of readily floating away from the needle when cord penetration is attempted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Intrahepatic umbilical vein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Puncture of the intrahepatic portion of the umbilical vein has several advantages. There is a low incidence of fetal bradycardia, probably due to absence of inadvertent umbilical artery puncture at this anatomical level [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/31\">",
"     31",
"    </a>",
"    ]. Additionally, blood loss from the cord puncture site is compensated, at least in part, by its subsequent absorption from the peritoneal cavity. A disadvantage is that IVT using the intrahepatic umbilical vein may result in a greater degree of fetal pain. The fetal stress hormones noradrenaline, cortisol, and beta-endorphin have been reported to increase with intrahepatic puncture, a response not seen with procedures at the placental insertion site [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/32\">",
"     32",
"    </a>",
"    ]. There is also concern that fetal movement during intrahepatic umbilical vein transfusion places the fetus at higher risk of organ trauma from a dislodged needle than when transfusion is performed at other sites. For this reason, some clinicians suggest administering a drug to induce fetal paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/29\">",
"     29",
"    </a>",
"    ], and others leave the needle unheld [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cases of poor visualization of a cord insertion due to posterior placentation, the use of the intrahepatic portion of the umbilical vein is a reasonable option when the fetus is properly positioned: the fetal spine must be towards the maternal back to allow access to the liver. The procedure-related fetal loss rate appears to be similar to or less than that with puncture of the umbilical vein (1.4 percent) (see",
"    <a class=\"local\" href=\"#H32\">",
"     'Complications'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/29,31\">",
"     29,31",
"    </a>",
"    ]. There are no data from randomized trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Combined approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;A combined approach (IVT followed by IPT) appears to provide a more stable fetal hematocrit between procedures, presumably due to slow absorption of RBCs from the intraperitoneal reservoir. This allows a longer interval between procedures, so fewer IUTs are needed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. One study using a combined approach administered packed RBCs by IVT to achieve a final fetal hematocrit of 35 to 40 percent, immediately followed by a standard IPT [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/34\">",
"     34",
"    </a>",
"    ]. The decline in fetal hematocrit between procedures was markedly reduced with this approach when compared to IVT alone (0.1 versus 1 percent decline per day).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Special circumstances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several circumstances deserve special mention:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92167611\">",
"    <span class=\"h3\">",
"     Gestational age less than 22 weeks",
"    </span>",
"    &nbsp;&mdash;&nbsp;If IUTs must be initiated early in the second trimester (&lt;22 weeks), particularly if the maternal habitus makes visualization of the cord insertion difficult, an IPT is often the best approach. In a cohort of six women with a history of high perinatal loss (66 percent mortality) due to severe fetal anemia prior to 20 weeks of gestation in previous pregnancies, the use of serial IPTs between 16 and 21 weeks in the subsequent pregnancy followed by IVT when technically feasible was associated with improved survival",
"    <span class=\"nowrap\">",
"     (6/7",
"    </span>",
"    survived to 20 weeks and all six of these fetuses survived to delivery) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92167618\">",
"    <span class=\"h3\">",
"     Fetal ascites",
"    </span>",
"    &nbsp;&mdash;&nbsp;If fetal ascites is present, blood placed by IPT will not be absorbed. In these cases, IVT by targeting the umbilical cord, intrahepatic portion of the umbilical vein, or in extreme cases, the fetal heart, is warranted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92167625\">",
"    <span class=\"h3\">",
"     Multiple gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"local\" href=\"#H30\">",
"     'Transfusion of multiple gestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TRANSFUSION VOLUME AND TARGET HEMATOCRIT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Intravascular transfusion",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92167666\">",
"    <span class=\"h3\">",
"     After 24 weeks of gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The volume of blood for IVT depends upon the initial fetal hematocrit, size of the fetus, the hematocrit of the transfused RBCs, and the target hematocrit. After 24 weeks of gestation, we aim for a target hematocrit of 40 to 50 percent (the normal fetal hematocrit is 37",
"    <span class=\"nowrap\">",
"     +/-",
"    </span>",
"    4 percent at 17 weeks rising to 43",
"    <span class=\"nowrap\">",
"     +/-",
"    </span>",
"    7 percent at term [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/5\">",
"     5",
"    </a>",
"    ]). We avoid transfusing the fetus to supraphysiologic hematocrit values (50 to 65 percent), as is done in some centers, as a fetal hematocrit greater than 50 percent is associated with a marked rise in whole blood viscosity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/36\">",
"     36",
"    </a>",
"    ], and can lead to complications [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The simplest method of calculating the volume of packed RBCs to be infused assumes a hematocrit of approximately 75 percent for the donor unit and uses a series of coefficients for increasing the initial fetal hematocrit by specific increments (",
"      <a class=\"graphic graphic_table graphicRef50073 \" href=\"UTD.htm?15/54/16235\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/39\">",
"       39",
"      </a>",
"      ]. As an example, to increase the hematocrit of a 1000 gram fetus from 20 to 40 percent, one multiplies 0.04 (coefficient for raising the hematocrit by 20) and 1000 (the estimated fetal weight in grams) to yield 40 mL (the volume that needs to be transfused).",
"     </li>",
"     <li>",
"      Another formula for calculating the amount of blood to be transfused is [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/40\">",
"       40",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Volume transfused (mL) = Volume of fetoplacental unit (mL) X (final - initial hematocrit) divided by the hematocrit of the transfused blood",
"   </p>",
"   <p>",
"    The fetoplacental volume (mL) is calculated from the ultrasound estimate of the fetal weight according to the formula (1.046 + fetal weight in grams X 0.14).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Before 24 weeks of gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute correction of fetal anemia is associated with profound hemodynamic changes. Cardiac output is markedly depressed due to increased afterload secondary to higher blood viscosity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/41\">",
"     41",
"    </a>",
"    ]. Severely anemic fetuses at 18 to 24 weeks of gestation are at highest risk, with 33 percent fetal mortality after IVT. Therefore, the final post-transfusion hematocrit at these early gestations should not exceed 25 percent or a four-fold increase from the pre-transfusion value [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/42\">",
"     42",
"    </a>",
"    ]. A second IVT is performed within 48 hours to bring the fetal hematocrit into the normal range; the third procedure is scheduled in 7 to 10 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Intraperitoneal transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The formula for the volume of intraperitoneal transfusion was determined many years ago to allow for the maximum infusion of red cells without compromising umbilical venous blood flow due to excessive intraabdominal pressure. The calculation involves subtracting 20 from the gestational age in weeks and multiplying by a factor of 10 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/43\">",
"     43",
"    </a>",
"    ]. Thus, a 30-week fetus would receive 100 mL of blood. Blood in the peritoneal reservoir can be expected to be absorbed over a 7- to 10-day period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     ANTENATAL CORTICOSTEROIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;We usually administer a course of antenatal corticosteroids to women &ge;26 weeks of gestation before their first IUT in case an emergency delivery is needed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31610?source=see_link\">",
"     \"Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PROCEDURE FOR UMBILICAL VEIN TRANSFUSION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Gestational age at first transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;IVTs are rarely successful prior to 18 weeks of gestation due to limited visualization and small size of the relevant anatomic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/44\">",
"     44",
"    </a>",
"    ]. After 35 weeks of gestation, a fetal transfusion is generally considered riskier than delivery for neonatal treatment of severe anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For the rare patient who has very early, severe alloimmunization, medical therapy may maintain the fetal hematocrit above life-threatening levels long enough to achieve a gestational age when IUT is technically feasible. A small case series described successful outcome using maternal single volume plasmapheresis (three procedures after the 12th week of gestation) followed by weekly administration of intravenous immune globulin (1",
"    <span class=\"nowrap\">",
"     g/kg)",
"    </span>",
"    until 20 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/46\">",
"     46",
"    </a>",
"    ]. All nine fetuses subsequently required IUTs.",
"   </p>",
"   <p>",
"    IPT is also an option for early onset disease in fetuses under 18 to 20 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;IUT in previable fetuses can be performed in the ultrasound suite; however, if the fetus has attained a viable gestational age, many centers perform IUTs in an operating room on the Labor and Delivery unit because a serious complication (eg, prolonged bradycardia) may necessitate an emergency cesarean delivery. Patients are usually instructed to avoid oral intake for six to eight hours before the procedure and a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    lock is placed for intravenous access.",
"   </p>",
"   <p>",
"    The uterus is displaced to the left to reduce the risk of maternal hypotension and the abdomen is prepared and draped as for a surgical procedure. Some clinicians administer prophylactic antibiotics that are effective against skin flora; no data are available on the value of antibiotic prophylaxis in this setting. Maternal sedation (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    1 to 2 mg or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    25 to 50 mcg intravenously) may be administered if needed to reduce maternal anxiety.",
"   </p>",
"   <p>",
"    One operator supplies ultrasound guidance using a transducer covered with a sterile sleeve. The cord insertion site is identified, the skin infiltrated with a local anesthetic, then a 20-gauge six-inch needle is directed into the umbilical vein under continuous real-time ultrasound visualization. A 22-gauge needle is preferred for gestations of less than 22 weeks.",
"   </p>",
"   <p>",
"    An initial sample of blood is withdrawn for complete blood count and reticulocyte count. Although a spun capillary hematocrit is adequate, we have found the use of a portable automated hemocytometer (eg, Coulter counter) to be more useful. The automated method is fast and mean corpuscular red cell volume (MCV) can be determined and used during the first few transfusions as a method of affirming that fetal, as opposed to maternal, blood has been obtained (MCV greater than 100 mL suggests fetal RBCs). Injection of saline with visualization of turbulence within the umbilical vein is another method of confirming proper needle position.",
"   </p>",
"   <p>",
"    After withdrawing a blood sample, we give a short acting paralytic agent to minimize fetal movement. Options include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15079?source=see_link\">",
"     vecuronium",
"    </a>",
"    (0.1 mg per kg of ultrasound estimated fetal weight) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/48\">",
"     48",
"    </a>",
"    ] or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/14/6374?source=see_link\">",
"     atracurium",
"    </a>",
"    besylate (0.4 mg per kg of estimated fetal weight) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/49\">",
"     49",
"    </a>",
"    ], drugs which are associated with minimal fetal cardiovascular effects. Both agents cause fetal paralysis for up to two hours. Fetal paralysis appears to improve the safety of fetal transfusion, and may prevent 80 percent of procedure-related fetal heart rate changes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the fetus is anemic (ie, hematocrit less than 30 percent or two standard deviations below the mean for gestational age), a second operator infuses packed RBCs using a 20 cc syringe attached to a three-way stopcock connected, via extension tubing, to the blood bag and the procedure needle. In addition, a nonluer lock stopcock is used to connect the procedure needle and distal end of the extension tubing to facilitate manipulation of the tubing without disturbing the needle. During the infusion, the primary operator should be able to visualize the transfused blood streaming away from the needle in the umbilical vein as it mixes with fetal blood.",
"   </p>",
"   <p>",
"    The fetal heart rate should be monitored periodically using color flow or pulsed Doppler ultrasound. Swirling at the tip of the needle (as opposed to streaming inside the vein away from the tip of the needle) indicates a decrease in fetal cardiac output and the need to check for fetal bradycardia. Bradycardia usually responds to slowing or stopping the transfusion, needle removal, maternal oxygen administration, and repositioning in the left lateral decubitus position. If bradycardia occurs, we initially stop the infusion and then restart at a slower rate if the fetal heart rate promptly recovers. If bradycardia persists for more than 30 seconds, the procedure needle should be removed and the fetal heart rate continuously monitored by ultrasound. Visualization of opening and closing of the atrioventricular valves (AV) indicates continued fetal cardiac output. The fetal heart should be observed continuously; if severe bradycardia persists for more than three minutes, we would perform an emergency cesarean delivery in pregnancies of a viable gestational age. If the AV valves are not moving (ie, cardiac arrest), delivery by emergent cesarean delivery is warranted if the fetus is of a viable gestational age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Posttransfusion monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the infusion has been completed, another fetal blood sample is obtained for posttransfusion complete blood count. We also perform a Kleihauer-Betke test or fetal cell staining using flow cytometry to determine the proportion of adult RBCs, which indicates the extent of suppression of fetal erythropoiesis after the first transfusion.",
"   </p>",
"   <p>",
"    Fetal heart rate monitoring is continued until resumption of fetal movement and a reactive tracing are documented. An ultrasound examination is scheduled for the following day, as most cases of fetal loss occur within the first 24 hours post-procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     TIMING TRANSFUSION FREQUENCY IN ALLOIMMUNIZATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Second and subsequent transfusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the first IUT, a decline in fetal hematocrit of approximately 1 percent per day can be expected if the fetus is not hydropic (1.88 percent if the fetus is hydropic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/50\">",
"     50",
"    </a>",
"    ]). Therefore, a second IUT is planned 10 to 14 days after the first IUT, depending upon the final hematocrit achieved at the conclusion of that transfusion. Predicting the fetal hematocrit after a transfusion is an inexact process given fluid shifts from the extravascular to the intravascular compartment, bleeding from the cord puncture site when the needle is removed, and possibly from decreased survival of adult RBCs in the fetal circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/51-53\">",
"     51-53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After the first two or three transfusions, the interval between subsequent procedures can usually be lengthened to three to four weeks because of suppression of fetal erythropoiesis, as noted by Kleihauer-Betke stain or fetal cell staining by flow cytometry and reticulocyte count [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/51,52,54\">",
"     51,52,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some centers base the interval between transfusions on the expected decline in fetal hemoglobin of 0.4",
"    <span class=\"nowrap\">",
"     g/dL/day,",
"    </span>",
"    0.3",
"    <span class=\"nowrap\">",
"     g/dL/day,",
"    </span>",
"    and 0.2",
"    <span class=\"nowrap\">",
"     g/dL/day",
"    </span>",
"    after the first, second, and third transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/55\">",
"     55",
"    </a>",
"    ] or empirically transfuse 10 days, two weeks, and three weeks after the first, second, and third transfusion, respectively.",
"   </p>",
"   <p>",
"    Doppler ultrasound measurement of the peak systolic velocity of the fetal middle cerebral artery has also been investigated for the timing of the second intrauterine transfusion. In one study, a threshold value of 1.69 MoM's predicted all cases of severe fetal anemia with a false positive rate of 6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/56\">",
"     56",
"    </a>",
"    ]. A threshold value of 1.32 MoM's predicted all cases of moderate anemia with a false positive rate of 37 percent. The authors concluded that higher peak systolic values should be used to detect severe anemia after IUTs have been initiated than when the fetus has never undergone IUT (threshold 1.50 MoM). After two transfusions, a 1.50 MoM threshold only detected 64 percent of fetuses with severe anemia (hemoglobin deficit &gt;6",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/55\">",
"     55",
"    </a>",
"    ]. Proposed explanations for the higher threshold included a change in the rheology of the fetal blood due to the presence of adult-hemoglobin containing donor red cells, as well as a change in the fetal cerebral circulation due to the differential oxygen binding capacity of these transfused red cells.",
"   </p>",
"   <p>",
"    If one uses middle cerebral artery Doppler for determining when to undertake the second transfusion, the threshold for performing the second transfusion should be 1.32 MoM, which correlates with moderate to severe anemia in the fetus who has undergone a single intrauterine transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/56\">",
"     56",
"    </a>",
"    ]. However, there are really no good data to support the use of middle cerebral artery (MCA) Doppler to decide when to repeat transfusions, and most experts use the empiric intervals described above for timing the frequency of transfusion.",
"   </p>",
"   <p>",
"    Published data and anecdotal clinical experience do not support the use of middle cerebral artery Doppler assessment to time serial IUTs beyond the first two transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/57\">",
"     57",
"    </a>",
"    ]. After two previous intrauterine transfusions, 66 to 100 percent of the fetus' red cells contain adult hemoglobin. In this setting, where most of the fetal red cells have been replaced by donor cells, MCA-PSV loses its ability to discriminate moderate-to-severe fetal anemia from mild anemia. Studies performing both cordocentesis and Doppler velocimetry prior to a third transfusion have reported that a cut-off MCA-PSV of &gt;1.50 MoM would have missed 20 to 33 percent of cases of severe anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/55,58\">",
"     55,58",
"    </a>",
"    ]. MCA-PSV has lower accuracy after multiple transfusions presumably because adult red cells are smaller, less rigid, and show increased erythrocyte aggregation compared to fetal red cells, and thus the relationship between blood velocity and hemoglobin concentration is different.",
"   </p>",
"   <p>",
"    Rapid normalization of MCA occurs after fetal transfusion. As an example, a study of fetuses with mean hemoglobin of 7.2 &plusmn; 3",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    determined MCA before and immediately after initial intrauterine transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/59\">",
"     59",
"    </a>",
"    ]. Mean MCA dropped from an elevated to normal level, 52.8 &plusmn; 21.5 to 30.9 &plusmn; 6.9",
"    <span class=\"nowrap\">",
"     cm/s.",
"    </span>",
"    This probably indicates an acute change in the abnormal fetal physiology associated with the anemic state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Last transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most centers perform fetal transfusions up to 35 weeks of gestation. We suggest maternal administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    (30 mg orally three times per day for 10 days) after the last transfusion to enhance fetal hepatic maturity. In a series of 71 patients with hemolytic disease of the",
"    <span class=\"nowrap\">",
"     fetus/newborn",
"    </span>",
"    who underwent intrauterine transfusion, 33 patients received phenobarbital prior to delivery; 38 patients did not, primarily because many delivered shortly after the last transfusion due to nonreassuring antenatal testing or a mature fetal lung profile [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/60\">",
"     60",
"    </a>",
"    ]. Patients in the phenobarbital group had significantly fewer neonatal exchange transfusions (adjusted relative risk 0.23, 95% CI 0.06-0.76). A randomized trial is needed to better define the efficacy of short-term phenobarbital in reducing the need for neonatal exchange transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     TRANSFUSION OF MULTIPLE GESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of IUTs in multiple gestations have been limited to case descriptions in twins. The largest series reported to date included only five pregnancies: four cases of dichorionic twin gestations and one case of monochorionic twins [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/61\">",
"     61",
"    </a>",
"    ]. In the one case of monochorionic gestation, the IUT of one fetus was quickly followed by the movement of donor red cells through intraplacental anastomoses, as illustrated by a positive Kleihauer-Betke stain at the time of fetal blood sampling of the second twin. In the subsequent IUTs, the transfusion of only one member of the twin pair resulted in adequate levels of hemoglobin in both twins.",
"   </p>",
"   <p>",
"    Since intraplacental anastomoses are rare in dichorionic twins, each fetus should undergo sampling and the amount to be transfused for IUT calculated in a similar fashion as a singleton. There are insufficient data to guide therapy in monochorionic twins, a situation where intraplacental anastomoses are almost universal. One suggested approach would be to measure the peak MCA velocity in the non-targeted twin as a baseline. After the first twin has been transfused to the desired hematocrit, a repeat MCA could be undertaken in the non-targeted twin while the patient is still in the operative setting. A normalization of the previously elevated MCA peak systolic velocity would indicate that the suspected anemia in the second twin fetus has been corrected through inter-twin transfusion.",
"   </p>",
"   <p>",
"    In multiple gestations in which all fetuses need to undergo IVT, use of the intrahepatic portion of the umbilical vein for access will allow for correct identification of each fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     TIMING OF DELIVERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Induction of labor is undertaken approximately three weeks after the last IUT. Fetal lung maturity should be determined if delivery is preterm. We suggest using the lamellar body count, as this test is not affected by blood or bilirubin in the amniotic fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42919?source=see_link\">",
"     \"Assessment of fetal lung maturity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Procedure related complications of IPT were illustrated in a series describing the outcome of 77 fetal IPTs in 35 pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/63\">",
"     63",
"    </a>",
"    ]. Transfusion-related complications occurred in five cases (two fetal colon infusions, two fetal retroperitoneal infusions, one fetal abdominal wall hematoma), but no fetus died, required urgent delivery, or suffered long-term sequelae. These procedures were performed under direct ultrasound guidance and with intensive perinatal management. Series from the pre-ultrasound era reported higher complication rates, but these procedures were performed without continuous visualization and other modern enhancements [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/64,65\">",
"     64,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risks of IVT were best illustrated by a large series reported from a single hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/29\">",
"     29",
"    </a>",
"    ]. This series of 740 IVTs in 254 patients described the following procedure related complication rates:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perinatal death: 1.6 percent per procedure",
"     </li>",
"     <li>",
"      Emergency cesarean delivery: 2.0 percent per procedure",
"     </li>",
"     <li>",
"      Infection: 0.3 percent per procedure",
"     </li>",
"     <li>",
"      Premature rupture of membranes: 0.1 percent per procedure",
"     </li>",
"     <li>",
"      Inadvertent arterial puncture: 3 percent",
"     </li>",
"     <li>",
"      Bradycardia or tachycardia: 5 percent of procedures (but 57 percent of procedures resulting in perinatal death or emergency delivery)",
"     </li>",
"     <li>",
"      Bleeding from puncture site: 0 to 17 minutes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The total procedure related complication rate, corrected for procedures with more than one complication, was 3.1 percent.",
"   </p>",
"   <p>",
"    Other risks associated with IVT have been described primarily in case reports and are not quantifiable:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bleeding from the puncture site can cause a cord hematoma, worsen anemia, or lead to exsanguination. Most cord hematomas resolve without fetal sequelae, but a large hematoma that compresses the umbilical vessels may cause fetal compromise [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fetal brain injury may occur, possibly related to changes in intravascular volume, hemodynamics,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      viscosity [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/37,67\">",
"       37,67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Risks associated with either IVT or IPT include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cord trauma or visceral injury from fetal movement. These risks are minimized with use of paralytic agents.",
"     </li>",
"     <li>",
"      Transplacental needle insertion can result in significant fetal bleeding if a large fetoplacental vessel is lacerated. Fetomaternal hemorrhage can also occur and potentially increase maternal alloantibody titers as well as severity of hemolytic disease in the index or future pregnancies [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Viral or bacterial agents can be transmitted from needle insertion or infused blood [",
"      <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overall survival after IUT is about 89 percent, but varies with center, experience, and the presence of hydrops fetalis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/70\">",
"     70",
"    </a>",
"    ]. Survival of hydropic fetuses is lower than that of fetuses who are not hydropic at first IUT (70 versus 92 percent). Results from a single treatment center where 213 fetuses received 599 IUTs were similar to the multicenter experience: survival with any degree of hydrops was 78 percent as compared to 92 percent for nonhydropic fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Survival is also lower when severe anemia occurs at less than 20 weeks of gestation. The higher rate of fetal loss at early gestational ages reflects the technical difficulties of invasive therapy in a very small fetus, as well as the inability of the very immature fetus to tolerate the hemodynamic changes of severe anemia and the hemodynamic changes following transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/67,72,73\">",
"     67,72,73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Neonatal transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the neonatal hematocrit is near normal because of a recent IUT, neonatal exchange transfusion may not be necessary. With senescence of the transfused red cells, approximately 50 percent of these infants will require a \"top-up\" transfusion at one month of age due to suppression of fetal erythropoiesis from IUT and persistence of maternal antibody not removed by exchange transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/74\">",
"     74",
"    </a>",
"    ]. In some cases, up to four top-up transfusions may be necessary before reticulocytosis begins and anti-red cell antibodies disappear [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/75\">",
"     75",
"    </a>",
"    ]. Management of these infants is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10665?source=see_link\">",
"     \"Postnatal diagnosis and management of alloimmune hemolytic disease of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Neurologic outcome",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32211954\">",
"    <span class=\"h3\">",
"     Hemolytic disease of the fetus/newborn",
"    </span>",
"    &nbsp;&mdash;&nbsp;One long-term concern of IUT is that advances in treatment techniques have allowed more moribund and hydropic fetuses to survive and these infants may be at higher risk of long-term morbidity. Available data are reassuring, but are limited to mostly small series [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/76-81\">",
"     76-81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The LOTUS study is the largest study to assess the incidence and risk factors for neurodevelopmental impairment in children with hemolytic disease of the",
"    <span class=\"nowrap\">",
"     fetus/newborn",
"    </span>",
"    treated with IUT [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/82\">",
"     82",
"    </a>",
"    ]. Alloimmunization was related to Rh(D) in 80 percent of cases, 26 percent of the fetuses were hydropic, the mean gestational age at first transfusion was 26 weeks, the mean number of transfusion was 3, and all of the pregnancies were delivered between 35 and 37 weeks of gestation. Major findings at follow-up at median age 8.2 years (range 2 to 17 years) were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolated severe developmental delay:",
"      <span class=\"nowrap\">",
"       5/291",
"      </span>",
"      (1.7 percent)",
"     </li>",
"     <li>",
"      Isolated cerebral palsy:",
"      <span class=\"nowrap\">",
"       2/291",
"      </span>",
"      (0.7 percent)",
"     </li>",
"     <li>",
"      Isolated bilateral deafness:",
"      <span class=\"nowrap\">",
"       3/291",
"      </span>",
"      (1.0 percent)",
"     </li>",
"     <li>",
"      Cerebral palsy and severe developmental delay:",
"      <span class=\"nowrap\">",
"       4/291",
"      </span>",
"      (1.4 percent)",
"     </li>",
"     <li>",
"      Composite neurodevelopmental impairment (cerebral palsy, severe development delay, bilateral deafness, or blindness):",
"      <span class=\"nowrap\">",
"       14/291",
"      </span>",
"      (4.8 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This incidence of severe neurodevelopmental delay (3.1 percent) was similar to that of the normal Dutch population (2.3 percent). However, the incidence of cerebral palsy (2.1 percent) was higher than expected in a normal population (0.7 percent with delivery between 32 and 36 weeks and 0.2 percent with delivery at 37 weeks of gestation or greater).",
"   </p>",
"   <p>",
"    The major risk factor for neurodevelopmental impairment was hydrops, which was present in",
"    <span class=\"nowrap\">",
"     9/14",
"    </span>",
"    (64 percent) children with neurodevelopmental impairment versus",
"    <span class=\"nowrap\">",
"     66/277",
"    </span>",
"    (24 percent) without; in a multivariate regression model, severe hydrops but not mild hydrops was a significant independent risk factor.",
"   </p>",
"   <p>",
"    High neonatal bilirubin levels due to increased red blood cell destruction may cause hearing loss. Phototherapy and exchange transfusion are the two major modalities used to prevent complications from hyperbilirubinemia, but hearing loss has been reported rarely despite therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/57/13210/abstract/77\">",
"     77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/59/21434?source=see_link\">",
"     \"Treatment of unconjugated hyperbilirubinemia in term and late preterm infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Kernicterus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32211961\">",
"    <span class=\"h3\">",
"     Parvovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited, small series and studies of hydropic fetuses undergoing IUT's for parvovirus infection suggest that these children are at increased risk of delayed psychomotor development. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/29/40408?source=see_link&amp;anchor=H22#H22\">",
"     \"Parvovirus B19 infection during pregnancy\", section on 'Intrauterine blood transfusion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrauterine transfusion is indicated for treatment of severe fetal anemia, which may result from red cell alloimmunization, parvovirus infection, chronic fetomaternal hemorrhage, or inherited red cell disorders. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We initiate transfusion when the fetal hematocrit falls below 30 percent or two standard deviations below the mean hematocrit for gestational age. Intervention at this level of anemia is more likely to be successful and less likely to result in fetal complications than when attempted on the hydropic fetus. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fetal transfusions are rarely successful prior to 18 weeks of gestation due to limited visualization and the small size of the relevant anatomic structures. In utero transfusions are not performed after 35 weeks of gestation because procedure related morbidity exceeds morbidity associated with delivery. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Gestational age at first transfusion'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H31\">",
"       'Timing of delivery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For the hydropic fetus, we recommend intravascular transfusion (IVT) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). IVT results in significantly higher survival rates than intraperitoneal transfusion (IPT) in this population. For nonhydropic fetuses, we suggest IVT (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). IVT appears to be more effective and its effects are more rapid than IPT, but both procedures are effective. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Choice of access site'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest using the umbilical vein near the placental insertion site or the intrahepatic vein for intravenous transfusion. There is an increased risk of complications from transfusion into the umbilical artery or into a free floating loop of cord. The umbilical artery should always be avoided, and the free floating cord used only as a last resort. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Choice of access site'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We aim for a target hematocrit of 40 to 50 percent. The volume of blood for intravascular transfusion is calculated from a formula and depends upon the initial fetal hematocrit, size of the fetus, the hematocrit of the transfused RBCs, and the target hematocrit. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Transfusion volume and target hematocrit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest administering a short-acting paralytic agent to the fetus (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Reduction in fetal movement reduces the risk of complications. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After the first transfusion, a decline in fetal hematocrit of approximately 1 percent per day can be expected. After the first two transfusions, which are 10 to 14 days apart, the interval between subsequent procedures usually can be lengthened to three to four weeks because of suppression of fetal erythropoiesis. Doppler ultrasound measurement of the peak systolic velocity of the fetal middle cerebral artery can be used for timing the second intrauterine transfusion, but the utility of using middle cerebral artery (MCA) Doppler to determine the interval between the second and third transfusions has not been verified. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Timing transfusion frequency in alloimmunization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Packed red blood cells used for intrauterine transfusion must undergo the same testing that occurs for any red cell donor unit. In addition, these units should be fresh, depleted of leukocytes, irradiated, tightly packed to a final hematocrit of 75 to 85 percent, and type O Rh(D) negative. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Blood for transfusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We give the mother",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"       phenobarbital",
"      </a>",
"      (30 mg orally three times per day) for 10 days after the last transfusion to enhance fetal hepatic maturity and reduce the need for neonatal exchange transfusion (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Last transfusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The best estimate of risk of procedure-related fetal loss is 1 to 2 percent and the overall risk of procedure-related complications is 3 percent. Fetal bleeding, infection, and trauma account for most of the mortality and morbidity. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Overall survival after intrauterine transfusion is about 85 percent, but varies with center, experience, and the presence of hydrops fetalis. Survival of hydropic fetuses is lower than that of fetuses who are not hydropic at first transfusion. (See",
"      <a class=\"local\" href=\"#H34\">",
"       'Survival'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Normal neurologic outcome can be expected in over 90 percent of surviving infants, even if hydrops fetalis is noted at the time of the first transfusion. (See",
"      <a class=\"local\" href=\"#H36\">",
"       'Neurologic outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/1\">",
"      LILEY AW. INTRAUTERINE TRANSFUSION OF FOETUS IN HAEMOLYTIC DISEASE. Br Med J 1963; 2:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/2\">",
"      Rodeck CH, Kemp JR, Holman CA, et al. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation. Lancet 1981; 1:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/3\">",
"      Nicolaides KH, Soothill PW, Clewell WH, et al. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1988; 1:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/4\">",
"      Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/5\">",
"      Forestier F, Daffos F, Catherine N, et al. Developmental hematopoiesis in normal human fetal blood. Blood 1991; 77:2360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/6\">",
"      von Kaisenberg CS, Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 2001; 18:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/7\">",
"      Carr S, Rubin L, Dixon D, et al. Intrauterine therapy for homozygous alpha-thalassemia. Obstet Gynecol 1995; 85:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/8\">",
"      Ng PC, Fok TF, Lee CH, et al. Is homozygous alpha-thalassaemia a lethal condition in the 1990s? Acta Paediatr 1998; 87:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/9\">",
"      Hayward A, Ambruso D, Battaglia F, et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn Ther 1998; 13:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/10\">",
"      Wang C, Ryan G. Transfusion medicine illustrated: Intrauterine transfusion for homozygous alpha(0) thalassemia reverses hydrops fetalis. Transfusion 2009; 49:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/11\">",
"      Remacha AF, Badell I, Pujol-Moix N, et al. Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 2002; 100:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/12\">",
"      Ogburn PL Jr, Ramin KD, Danilenko-Dixon D, et al. In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis. Am J Obstet Gynecol 2001; 185:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/13\">",
"      Quarello E, Stirnemann J, Nassar M, et al. Outcome of anaemic monochorionic single survivors following early intrauterine rescue transfusion in cases of feto-fetal transfusion syndrome. BJOG 2008; 115:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/14\">",
"      Herway C, Johnson A, Moise K, Moise KJ Jr. Fetal intraperitoneal transfusion for iatrogenic twin anemia-polycythemia sequence after laser therapy. Ultrasound Obstet Gynecol 2009; 33:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/15\">",
"      Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force. Transfus Med 1996; 6:261.",
"     </a>",
"    </li>",
"    <li>",
"     Vengelen-Tyler, V. Technical Manual of the American Association of Blood Banks. Bethesda, Maryland: American Association of Blood Banks, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/17\">",
"      Vi&euml;tor HE, Kanhai HH, Brand A. Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion 1994; 34:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/18\">",
"      Schonewille H, Klumper FJ, van de Watering LM, et al. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 2007; 196:143.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/19\">",
"      Watson WJ, Wax JR, Miller RC, Brost BC. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. Am J Perinatol 2006; 23:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/20\">",
"      el-Azeem SA, Samuels P, Rose RL, et al. The effect of the source of transfused blood on the rate of consumption of transfused red blood cells in pregnancies affected by red blood cell alloimmunization. Am J Obstet Gynecol 1997; 177:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/21\">",
"      Dodd JM, Windrim RC, van Kamp IL. Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes. Cochrane Database Syst Rev 2012; 9:CD007096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/22\">",
"      Harman CR, Bowman JM, Manning FA, Menticoglou SM. Intrauterine transfusion--intraperitoneal versus intravascular approach: a case-control comparison. Am J Obstet Gynecol 1990; 162:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/23\">",
"      Fox C, Martin W, Somerset DA, et al. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion. Fetal Diagn Ther 2008; 23:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/24\">",
"      Lewis M, Bowman JM, Pollock J, Lowen B. Absorption of red cells from the peritoneal cavity of an hydropic twin. Transfusion 1973; 13:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/25\">",
"      Creasman WT, Duggan ER, Lund CJ. Absorption of transfused chromium-labeled erythrocytes from the fetal peritoneal cavity in hydrops fetalis. Am J Obstet Gynecol 1966; 94:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/26\">",
"      Taylor WW, Scott DE, Pritchard JA. Fate of compatible adult erythrocytes in the fetal peritoneal cavity. Obstet Gynecol 1966; 28:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/27\">",
"      Westgren M, Selbing A, Stangenberg M. Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation. Br Med J (Clin Res Ed) 1988; 296:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/28\">",
"      Weiner CP, Wenstrom KD, Sipes SL, Williamson RA. Risk factors for cordocentesis and fetal intravascular transfusion. Am J Obstet Gynecol 1991; 165:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/29\">",
"      Van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005; 192:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/30\">",
"      Ellison JP. The nerves of the umbilical cord in man and the rat. Am J Anat 1971; 132:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/31\">",
"      Nicolini U, Santolaya J, Ojo OE, et al. The fetal intrahepatic umbilical vein as an alternative to cord needling for prenatal diagnosis and therapy. Prenat Diagn 1988; 8:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/32\">",
"      Giannakoulopoulos X, Sepulveda W, Kourtis P, et al. Fetal plasma cortisol and beta-endorphin response to intrauterine needling. Lancet 1994; 344:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/33\">",
"      Nicolini U, Nicolaidis P, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein: analysis of safety and clinical experience with 214 procedures. Obstet Gynecol 1990; 76:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/34\">",
"      Moise KJ Jr, Carpenter RJ Jr, Kirshon B, et al. Comparison of four types of intrauterine transfusion: effect on fetal hematocrit. Fetal Ther 1989; 4:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/35\">",
"      Nicolini U, Kochenour NK, Greco P, et al. When to perform the next intra-uterine transfusion in patients with Rh allo-immunization: combined intravascular and intraperitoneal transfusion allows longer intervals. Fetal Ther 1989; 4:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/36\">",
"      Welch R, Rampling MW, Anwar A, et al. Changes in hemorheology with fetal intravascular transfusion. Am J Obstet Gynecol 1994; 170:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/37\">",
"      Dildy GA 3rd, Smith LG Jr, Moise KJ Jr, et al. Porencephalic cyst: a complication of fetal intravascular transfusion. Am J Obstet Gynecol 1991; 165:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/38\">",
"      Drew JH, Guaran RL, Cichello M, Hobbs JB. Neonatal whole blood hyperviscosity: the important factor influencing later neurologic function is the viscosity and not the polycythemia. Clin Hemorheol Microcirc 1997; 17:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/39\">",
"      Giannina G, Moise KJ Jr, Dorman K. A simple method to estimate volume for fetal intravascular transfusions. Fetal Diagn Ther 1998; 13:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/40\">",
"      Mandelbrot L, Daffos F, Forestier F, et al. Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther 1988; 3:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/41\">",
"      Moise KJ Jr, Mari G, Fisher DJ, et al. Acute fetal hemodynamic alterations after intrauterine transfusion for treatment of severe red blood cell alloimmunization. Am J Obstet Gynecol 1990; 163:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/42\">",
"      Radunovic N, Lockwood CJ, Alvarez M, et al. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol 1992; 79:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/43\">",
"      Bowman JM. The management of Rh-Isoimmunization. Obstet Gynecol 1978; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/44\">",
"      Canlorbe G, Mac&eacute; G, Cortey A, et al. Management of very early fetal anemia resulting from red-cell alloimmunization before 20 weeks of gestation. Obstet Gynecol 2011; 118:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/45\">",
"      Klumper FJ, van Kamp IL, Vandenbussche FP, et al. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation. Eur J Obstet Gynecol Reprod Biol 2000; 92:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/46\">",
"      Ruma MS, Moise KJ Jr, Kim E, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol 2007; 196:138.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/47\">",
"      Howe DT, Michailidis GD. Intraperitoneal transfusion in severe, early-onset Rh isoimmunization. Obstet Gynecol 2007; 110:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/48\">",
"      Daffos F, Forestier F, Mac Aleese J, et al. Fetal curarization for prenatal magnetic resonance imaging. Prenat Diagn 1988; 8:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/49\">",
"      Bernstein HH, Chitkara U, Plosker H, et al. Use of atracurium besylate to arrest fetal activity during intrauterine intravascular transfusions. Obstet Gynecol 1988; 72:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/50\">",
"      Lobato G, Soncini CS. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization. Fetal Diagn Ther 2008; 24:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/51\">",
"      Egberts J, van Kamp IL, Kanhai HH, et al. The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. Br J Obstet Gynaecol 1997; 104:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/52\">",
"      Lobato G, Soncini CS. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies. Arch Gynecol Obstet 2007; 276:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/53\">",
"      Egberts J, Hardeman MR, Luykx LM. Decreased deformability of donor red blood cells after intrauterine transfusion in the human fetus: possible reason for their reduced life span? Transfusion 2004; 44:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/54\">",
"      Mari G, Detti L, Oz U, et al. Accurate prediction of fetal hemoglobin by Doppler ultrasonography. Obstet Gynecol 2002; 99:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/55\">",
"      Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. Am J Obstet Gynecol 2006; 195:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/56\">",
"      Detti L, Oz U, Guney I, et al. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 2001; 185:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/57\">",
"      Moise KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol 2008; 198:161.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/58\">",
"      Mari, G, Zimmerman, R, Segata, M. Am J Obstet Gynecol 2005; 191:S149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/59\">",
"      Stefos T, Cosmi E, Detti L, Mari G. Correction of fetal anemia on the middle cerebral artery peak systolic velocity. Obstet Gynecol 2002; 99:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/60\">",
"      Trevett TN Jr, Dorman K, Lamvu G, Moise KJ Jr. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn. Am J Obstet Gynecol 2005; 192:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/61\">",
"      Lepercq J, Poissonnier MH, Coutanceau MJ, et al. Management and outcome of fetomaternal Rh alloimmunization in twin pregnancies. Fetal Diagn Ther 1999; 14:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/62\">",
"      Cariappa R, Parvin CA, Gronowski AM. Bilirubin in amniotic fluid does not interfere with the Abbott TDx FLM II assay. Clin Chem 2003; 49:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/63\">",
"      Watts DH, Luthy DA, Benedetti TJ, et al. Intraperitoneal fetal transfusion under direct ultrasound guidance. Obstet Gynecol 1988; 71:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/64\">",
"      Queenan JT. Intrauterine transfusion. A cooperative study. Am J Obstet Gynecol 1969; 104:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/65\">",
"      Friesen RF. Complications of intrauterine transfusion. Clin Obstet Gynecol 1971; 14:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/66\">",
"      Keckstein G, Tsch&uuml;rtz S, Schneider V, et al. Umbilical cord haematoma as a complication of intrauterine intravascular blood transfusion. Prenat Diagn 1990; 10:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/67\">",
"      Ghi T, Brondelli L, Simonazzi G, et al. Sonographic demonstration of brain injury in fetuses with severe red blood cell alloimmunization undergoing intrauterine transfusions. Ultrasound Obstet Gynecol 2004; 23:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/68\">",
"      Nicolini U, Kochenour NK, Greco P, et al. Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ 1988; 297:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/69\">",
"      Evans DG, Lyon AJ. Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion. Eur J Pediatr 1991; 150:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/70\">",
"      Schumacher B, Moise KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996; 88:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/71\">",
"      van Kamp IL, Klumper FJ, Meerman RH, et al. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 2004; 83:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/72\">",
"      Poissonnier MH, Picone O, Brossard Y, Lepercq J. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization. Fetal Diagn Ther 2003; 18:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/73\">",
"      Yinon Y, Visser J, Kelly EN, et al. Early intrauterine transfusion in severe red blood cell alloimmunization. Ultrasound Obstet Gynecol 2010; 36:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/74\">",
"      Saade GR, Moise KJ, Belfort MA, et al. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions. Fetal Diagn Ther 1993; 8:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/75\">",
"      De Boer IP, Zeestraten EC, Lopriore E, et al. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008; 198:54.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/76\">",
"      Janssens HM, de Haan MJ, van Kamp IL, et al. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr 1997; 131:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/77\">",
"      Hudon L, Moise KJ Jr, Hegemier SE, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol 1998; 179:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/78\">",
"      Dembinski J, Haverkamp F, Maara H, et al. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002; 109:1232.",
"     </a>",
"    </li>",
"    <li>",
"     Moise, KJ, Whitecar PW. Antenatal therapy for haemolytic disease of the fetus and newborn. In: Alloimmune disorders in pregnancy. Anaemia, thrombocytopenia and neutropenia in the fetus and newborn, Hadley, A, Soothill, P (Eds), Cambridge University Press, Cambridge, UK 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/80\">",
"      Harper DC, Swingle HM, Weiner CP, et al. Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am J Obstet Gynecol 2006; 195:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/81\">",
"      Grab D, Paulus WE, Bommer A, et al. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years. Obstet Gynecol 1999; 93:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/57/13210/abstract/82\">",
"      Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012; 206:141.e1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5385 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-FBD0C7583D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13210=[""].join("\n");
var outline_f12_57_13210=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H37\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92167028\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92167051\">",
"      Causes of severe fetal anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Red cell alloimmunization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Parvovirus infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Chronic fetomaternal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Inherited RBC disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Complications after treatment of twin-twin transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      BLOOD FOR TRANSFUSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CHOICE OF ACCESS SITE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Peritoneal cavity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Direct vascular access",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Umbilical cord",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Intrahepatic umbilical vein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Combined approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Special circumstances",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H92167611\">",
"      - Gestational age less than 22 weeks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H92167618\">",
"      - Fetal ascites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H92167625\">",
"      - Multiple gestation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TRANSFUSION VOLUME AND TARGET HEMATOCRIT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Intravascular transfusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H92167666\">",
"      - After 24 weeks of gestation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Before 24 weeks of gestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Intraperitoneal transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      ANTENATAL CORTICOSTEROIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PROCEDURE FOR UMBILICAL VEIN TRANSFUSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Gestational age at first transfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Posttransfusion monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      TIMING TRANSFUSION FREQUENCY IN ALLOIMMUNIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Second and subsequent transfusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Last transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      TRANSFUSION OF MULTIPLE GESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      TIMING OF DELIVERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Neonatal transfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Neurologic outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32211954\">",
"      - Hemolytic disease of the fetus/newborn",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32211961\">",
"      - Parvovirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5385\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5385|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/53/25436\" title=\"table 1\">",
"      Normal range fetal hemoglobin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/54/16235\" title=\"table 2\">",
"      Coefficient for calculating volume for fetal transfusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=related_link\">",
"      Anemia in children due to decreased red blood cell production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31610?source=related_link\">",
"      Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42919?source=related_link\">",
"      Assessment of fetal lung maturity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=related_link\">",
"      Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/45/3800?source=related_link\">",
"      Diagnosis and management of massive fetomaternal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=related_link\">",
"      Laboratory testing of donated blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9913?source=related_link\">",
"      Management of twin-twin transfusion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32982?source=related_link\">",
"      Overview of Rhesus (Rh) alloimmunization in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/29/40408?source=related_link\">",
"      Parvovirus B19 infection during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10665?source=related_link\">",
"      Postnatal diagnosis and management of alloimmune hemolytic disease of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=related_link\">",
"      Preoperative autologous blood donation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/27/3513?source=related_link\">",
"      Significance of minor red blood cell antibodies during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/59/21434?source=related_link\">",
"      Treatment of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_57_13211="Systemic causes MS chest pain";
var content_f12_57_13211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rheumatic and systemic diseases associated with musculoskeletal chest wall pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ankylosing spondylitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psoriatic arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sternocostoclavicular hyperostosis (SAPHO syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibromyalgia (fibrositis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infectious arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relapsing polychondritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other systemic conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Osteoporosis, osteomalacia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tumors (benign, malignant, metastatic and primary)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sickle cell disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13211=[""].join("\n");
var outline_f12_57_13211=null;
var title_f12_57_13212="DSM IV criteria Asperger disorder";
var content_f12_57_13212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for Asperger disorder",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        A. Qualitative impairment in social interaction, as manifested by at least two of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        1. Marked impairments in the use of multiple nonverbal behaviors such as eye-to-eye gaze, facial expression, body postures, and gestures to regulate social interaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        2. Failure to develop peer relationships appropriate to developmental level",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        3. A lack of spontaneous seeking to share enjoyment, interests, or achievements with other people (eg, by a lack of showing, bringing, or pointing out objects of interest to other people)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        4. Lack of social or emotional reciprocity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        B. Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as manifested by at least one of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        1. Encompassing preoccupation with one or more stereotyped and restricted patterns of interest that are abnormal either in intensity or focus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        2. Apparently inflexible adherence to specific, nonfunctional routines or rituals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        3. Stereotyped and repetitive motor mannerisms (eg, hand or finger flapping or twisting, or complex whole-body movements)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        4. Persistent preoccupation with parts of objects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C. The disturbance causes clinically significant impairment in social, occupational, or other important areas of functioning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D. There is no clinically significant general delay in language (eg, single words used by age two years, communicative phrases used by age three years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. There is no clinically significant delay in cognitive development or in the development of age-appropriate self-help skills, adaptive behavior (other than social interaction), and curiosity about the environment in childhood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        F. Criteria are not met for another specific pervasive developmental disorder or schizophrenia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (Copyright 2000). American Psychiatric Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13212=[""].join("\n");
var outline_f12_57_13212=null;
var title_f12_57_13213="US patterns infectious diarrhea";
var content_f12_57_13213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F69867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F69867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sonographic pattern of infectious diarrhea (and important differential diagnosis) with respect to bowel wall thickening in the right and left colon, terminal ileum, mesenteric lymphadenopathy, and fluid filled small bowel",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Terminal ileum",
"       </td>",
"       <td class=\"subtitle1\">",
"        Right colon",
"       </td>",
"       <td class=\"subtitle1\">",
"        Left colon",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mesenteric lymphadenopathy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Fluid filled small bowel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Salmonella sp",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Campylobacter sp",
"       </td>",
"       <td>",
"        +(+)",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yersinia sp",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enterohemorrhagic ecoli",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tuberculosis",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudomembranous colitis",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Segmental hemorrhagic colitis",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antibiotic related diarrhea without colitis",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whipple's disease",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutropenic colitis",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        (-)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Virus related enteritis*",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytomegalovirus",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herpes simplex virus",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Giardia lamblia infection",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amebiasis",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        (+)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ischemic colitis",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Except CMV and Herpes simplex colitis.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13213=[""].join("\n");
var outline_f12_57_13213=null;
var title_f12_57_13214="Insulin glargine versus NPH";
var content_f12_57_13214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Time-action profiles for NPH and insulin glargine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 349px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Serum insulin concentrations after subcutaneous injection of 0.4 U/Kg body weight of insulin glargine (shown in red) or NPH human insulin (shown in blue) on&nbsp;two different study days in 15 normal subjects. In contrast to NPH insulin, the time-action profile for insulin glargine has virtually no peak which may make it an ideal basal insulin for intensive insulin therapy in patients with type 1 diabetes. To convert serum insulin values to &micro;U/mL, divide by 6.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Heinemann L, Linkeschova R, Rave K, et al. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000; 23:644.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13214=[""].join("\n");
var outline_f12_57_13214=null;
var title_f12_57_13215="Amenorrhea pain workup";
var content_f12_57_13215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Amenorrhea pain workup",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 617px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fujimoto, VY, Miller, JH, Klein, NA, Soules, MR. Congenital cervical atresia: Report of seven cases and review of the literature. Am J Obstet Gynecol 1977; 177:1419. Copyright &copy; 1977 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_57_13215=[""].join("\n");
var outline_f12_57_13215=null;
